Abstract
Aquaculture of molluscs and crustaceans represents an important and expanding sector within global food production. The intensification of these systems has been accompanied by an increased prevalence and severity of infectious diseases, which continue to constrain productivity and sustainability. Current disease management approaches include biosecurity measures, husbandry practices, therapeutics, and selective breeding, which have shown limited efficacy against many emerging pathogens affecting invertebrate species. Unlike finfish, aquatic invertebrates lack adaptive immunity and rely exclusively on innate immune mechanisms, limiting the effectiveness of traditional vaccine strategies. There is growing interest in immunostimulants that enhance innate defenses and support immune priming or trans-generational immune priming (TGIP). This review summarises the current understanding of immune defence mechanisms in molluscs and crustaceans and examines recent progress in the development of immunomodulators and prophylactic interventions aimed at improving health outcomes and disease resilience in invertebrate aquaculture.
1. Introduction
Invertebrate aquaculture, the cultivation of various species of shellfish including molluscs (abalone, conch, clams, oysters, mussels, scallops, and cockles) [1,2,3,4,5,6,7] and crustaceans (shrimps, prawns, lobsters, and crabs) [8,9,10,11] encompasses a diverse range of environments, including freshwater, marine, and coastal settings. The farming of molluscs and crustaceans plays a vital role in meeting global demands for seafood alongside popular finfish production at 65%, contributing approximately 23% and 11% in crustacean and molluscan products, respectively [12]. Demand for crustacean and molluscan products has increased in popularity, with aquaculture surpassing wild caught production in 2022, producing 94.4 million tonnes of aquatic animals, a 6.7 million-tonne increase from wild catch [12]. Crustaceans and molluscs make up 24.6% and 15.6% of this production, respectively, second only to finfish aquaculture at 58.1% [12]. Thus, crustacean and molluscan aquacultural farming is vital to meet global seafood consumption demands, where wild-caught fisheries fall short and fail to meet these demands due to strict fishing regulations to combat overfishing [13].
The intensification of invertebrate aquaculture has brought numerous challenges inhibiting production, most notably infection and disease such as viruses [14,15,16], bacteria [17,18,19], fungi [20,21], and parasites [22,23]. Moreover, as aquatic invertebrate species lack adaptive immunity, relying exclusively on nonspecific innate immune responses, traditional vaccine practices are not useful. Additionally, in contrast to vertebrate immunology, the mechanisms of innate immunity in non-model organisms remain inadequately characterised [24,25], making it challenging to design anti-infectives and placing an overreliance on strict biosecurity practices, which often prove to be inefficient as evidenced by ongoing outbreaks on farms.
Immunostimulants are becoming an attractive alternative to traditional vaccines for invertebrate aquaculture, as invertebrates lack the antibody-based adaptive immunity on which most conventional vaccines rely on and instead rely solely on innate immune systems [26]. These immunostimulants are described as substances or nutrients that can enhance a nonspecific immune response and protection against pathogens and disease [27,28]. They do not directly interact with the pathogen to reduce infection and disease; rather, they enhance the immune response of the host [29,30]. The extent of enhanced immune response can last for a long period of time, extending beyond treatment of the current infection or disease [31,32].
This review focusses on the application of immunostimulants within aquaculture as an alternative strategy for intensively farmed marine invertebrates and defines and explores immune priming and immune memory of invertebrates. Immunostimulants such as bacterial proteins (flagellins), nucleic acids (dsRNA and CpG), and carbohydrates (β-glucans, peptidoglycans and lipopolysaccharides) are critically compared, discussing the efficacy and effectiveness in protection against commonly occurring virulent diseases in marine animals. Furthermore, challenges to screening suitable immunostimulant candidates, synthesis, delivery, and toxicity are explored in connection with the current immunostimulants discussed. This review aims to provide overall progress into immunostimulant use for pathogen disease prevention and resilience for the aquatic invertebrate aquacultural farming systems by reviewing literature that has focussed on the use of immunostimulants for pathogen defence in pathogen challenge trials only.
2. Innate Immunity in Invertebrates of Aquaculture
The innate immune system of various aquatic invertebrates is composed of two different mechanisms: cellular and humoral. Cellular defence is mediated by haemocytes within the circulatory system that target and eliminate pathogens through cellular processes, such as phagocytosis, superoxide production, pathogen encapsulation, haemocyte nodulation, and enzyme release. Humoral defence targets and eliminates pathogens through processes such as melanisation, haemolymph agglutination, activation of prophenoloxidase (proPO), and the secretion of antimicrobial peptides (AMPs). Various immune responses are activated through the interaction of different pattern-associated molecular patterns (PAMPS) of different pathogens or immune activators and pathogen recognition receptors (PRRs). This interaction triggers various immune signalling pathways and effector molecules involved in cellular and humoral immunity for pathogen clearance (Figure 1).
Figure 1.
Humoral and cellular defence inferred from crustacean and molluscan immunology to achieve pathogen clearance. Crustacean and molluscan recognise pathogen-associated molecular patterns (PAMPs) by pathogen recognition receptors (PRRs) on immune cells and circulating haemocytes within the haemolymph. Upon recognition, cell-mediated immunity neutralises pathogens by phagocytosis, encapsulation, or melanisation. Melanisation is initiated by the precursor enzyme prophenoloxidase (proPO) to become phenoloxidase (PO). For humoral immunity, PAMP recognition stimulates the production of pro-inflammatory cytokines that activate the production of antimicrobial peptides (AMPs) or lead to lectin-induced agglutination, which ultimately results in pathogen killing directly or facilitating cell-mediated pathogen death through PO and opsonins. Created in BioRender. Ackerly, D. (2026) https://BioRender.com/qcfmxrq with this information summarised according to Rathinam et al. (2024) [33].
Multiple signalling pathways, PRRs, and immune effectors have been described for both crustaceans and molluscs, with many of these genes encoding innate immune receptors such as toll-like receptors (TLRs) to be homologous to those identified in vertebrate and mammalian species. However, within invertebrates, the number of TLRs are far more immense and largely undefined than the well-annotated and described 10–15 TLR families of vertebrates [34,35]. An example of this is observed in the Pacific oyster (Crassostrea gigas) [29] and the purple sea urchin (Stronglyocentrotus purpuratus) [36], which have approximately 83 and 222 TLR-encoding genes, with the mRNAs of these TLRs widely expressed in different tissue and stimulation by different PAMPS of Gram-negative/positive bacteria [37,38,39], viruses [40], fungal, parasitic, and immune stimulators [41,42]. Thus, suggesting that although these aquatic invertebrate species lack a highly specialised adaptive immune response typical of vertebrate and mammalian species, their innate immune defence has likely evolved to become more specialised to combat ongoing pathogen pressures.
3. Immune Priming and Trans-Generational Immune Priming
Immune priming is a phenomenon first described in arthropods, whereby there is an enhanced immune response to a pathogen or immune activator following previous exposure to a PAMP, resulting in enhanced humoral and cellular immune responses [43,44,45,46]. The exact mechanisms of immune priming have been largely debated, with nonspecific immune priming in invertebrates easily supported by a short-term elevation in generalised immune responses, such as that observed in increased haemocyte count, transcriptional changes of innate immune cells, and molecules such as AMPs. Thus, the definition of immune priming has varied amongst literature to include either of the following: increased survival to pathogen following infection in vivo, cytokine production, immune gene expression, and the up/downregulation of surface markers in circulating haemolymph fluid or within haemocytes challenged after priming in vivo or in vitro, as accepted by previous reviews [30,31,47,48,49]. Regardless of the exact mechanisms for confirmation of immune priming, all true immune priming experiments must involve the following: increased immune response, survival, and decreased pathogen load following a homologous challenge with a pathogen rather than a heterologous challenge (Figure 2A) [32,50,51].
Figure 2.
Flow-through diagram of (A) immune priming and (B) trans-generational immune priming experiments in molluscs and crustacean aquatic invertebrate species. Created in BioRender. Ackerly, D. (2026) https://BioRender.com/saod931.
Trans-generational immune priming (TGIP) expands on the immune priming phenomenon through the parental transfer of immunological protection against pathogens to the progeny (Figure 2B), whereby different immunological factors are transferred from parents to offspring, either vertically or horizontally between adults and non-parental juveniles [52]. These transferred components, such as immune effectors, signalling molecules, or PAMPS previously described in Section 2 can prime the innate immune system of offspring to better respond to pathogens previously encountered by their parents [31,32,52,53]. TGIP is typically nonspecific and maternally mediated, for example, through the transfer of AMPs to eggs during oogenesis [54]. However, the mechanisms underlying specific TGIP remain poorly understood and are debated [52,53]. For aquatic invertebrates, the first evidence of TGIP was reported in the shrimp Penaeus monodon, where maternal exposure to the fungal immunostimulant β-glucan enhanced offspring resistance to white spot syndrome virus (WSSV) [55]. TGIP has also been demonstrated in different molluscan species, albeit in far less studies than what has been recorded for crustaceans, with these studies restricted to bacterial whole-cell priming against pathogenic Vibrio spp. [56,57,58] and Polyinosinic-polycytidylic acid (Poly(I:C)) against the devastating viral Ostreid herpesvirus (OsHV-1) [59,60] discussed in more detail later in this review in Section 4.2 and Section 4.5. Although TGIP has since been observed in various invertebrates, its molecular basis, ecological relevance, and consistency across species remain uncertain. Inconsistencies in TGIP success are likely limited within the literature due to selective publication biases in overreporting positive results that support TGIP. Additionally, host–pathogen interactions, degree of pathogenic exposure, and timing between parental priming, conception, and challenge of progeny affecting TGIP success.
4. Immunostimulants Utilised for Immune Priming and Trans-Generational Immune Priming Experiments
4.1. Protein
4.1.1. Flagellin
Flagellin is a major protein of the bacterial flagellum and acts as an immune stimulant in vertebrates and some invertebrates. For aquatic invertebrates, flagellin is utilised as a vaccine adjuvant or research tool for understanding host–pathogen interactions [61,62,63,64]. Flagellin A (FlaA) has demonstrated antiviral activity against highly pathogenic WSSV in shrimp species, Marsupenaeus japonicus [65]. Shrimps intramuscularly injected with 1 μg per 5 g shrimp, reduced WSSV viral load at 24 and 48 h post infection, and increased survival by 40% 96 h post-WSSV challenge [65] (Table 1). Prior work discovered that FlaA of bacterial species Vibrio anguillarum interacted with shrimp scaffold protein, Shoc2, involved in activating antibacterial immune responses. FlaA activated extracellular signal-regulated kinase (Erk) and signal transducer and activator of transcription (Stat) signalling pathways through Shoc2 [63]. Stat signalling regulates several antiviral effectors, demonstrating a critical role in viral clearance and inhibition of viral replication through the regulation of ficolin [66,67,68]. Ficolin recognises and attaches to carbohydrates on the virion surface, enhancing phagocytosis and complement activation [69,70]. Thus, the antiviral properties of flagellin may occur in shrimps through the interaction between flagellins, Shoc2 proteins, and subsequent Erk/Stat signalling activating immune effectors, such as ficolin, that are directly involved in innate immunity.
Table 1.
Protein-based immunostimulants utilised in crustacean vaccination and immune priming experiments.
4.1.2. Structural Pathogen-Specific Components
Protein-based immunostimulants in crustacean immune priming experiments primarily target pathogen structural proteins, largely WSSV capsid proteins (VP28, VP19, VP26, VP24, and VP15), given their key roles in viral entry and assembly [72,73,74,75,76,77,78,79,80,81]. Numerous studies demonstrate these proteins enhance host protection across diverse crustaceans, including crayfish, freshwater prawns, and marine shrimp, although protection levels vary depending on the immunostimulant delivery method, concentration, and expression system employed [75,78,82,83,84]. Feed-based delivery of baculovirus-expressed VP28 produced slightly superior survival rates compared with immersion [85], while oral administration yielded protection levels marginally lower than intramuscular injection [77] (Table 2). Similar findings for M. japonicus, where intramuscular injection of recombinant VP28 (rVP28) conferred only a 4.3% higher survival than oral delivery 25 and 20 days post challenge, respectively [86]. Expression of VP19 and VP466 via baculoviral systems provided partial protection in Penaeus chinensis, with VP19-fed groups outperforming VP466, which exhibited approximately 40% lower efficacy [87].
Table 2.
Viral capsid protein-based immunostimulants utilised in crustacean vaccination and immune priming experiments.
In crayfish, intramuscular injection of VP28 achieved 91.2% and 78% survival at 3 and 21 days post vaccination, respectively, while VP19 elicited markedly lower protection (49.1% and 17.9%) [82]. A combination of both VP28 and VP19 demonstrated similar but lower protection at both timepoints (84.6% and 75.7%) compared to VP28 alone. Subsequent studies corroborated VP28’s superior efficacy across injection, immersion, and oral routes [83,94]. Injection remained the most effective route in P. monodon, Penaeus japonicus, and M. japonicus, consistent with crayfish studies, while baculoviral delivery of VP28 achieved comparable protection at 91.5% 30 days post challenge [88]. Similarly, in Cherax quadricarinatus, VP28 significantly outperformed VP26 and VP24 in conferring WSSV resistance [110], reinforcing VP28’s consistent immune-protection potential across crustaceans.
Recombinant expression of WSSV proteins in Escherichia coli and Bacillus subtilis has been the most prevalent in the literature [72,109]. Most notably, B. subtilis has emerged as a promising non-pathogenic, rapid, and cheap encapsulation method for oral delivery due to resilient spores [100,105,106,107]. B. subtilis spores expressing VP28 consistently provided higher efficacy (78.3%) compared to vegetative cells (5.17%) in Procambarus clarkii, with comparable results observed in Fenneropenaeus chinensis [100,105]. Comparable results occurred when VP28 fused with spore coat proteins (CotB/CotC) in Cambarus clarkii and Litopenaeus vannamei [106,107] and with VP26 fused to CotC in L. vannamei [108]. VP28 expression in Brevibacillus brevis and Brevibacillus chosshienensis also yielded high efficacy in P. japonicus, which reduced with time between priming and challenge, inactivation methods, and modifications in protein structure [95,96]. Algal (including Anabaena spp., Synechococcus spp., and Chlamydomonas reinhardtii) and yeast expression systems (including Pichia pastoris and Saccharomyces cerevisiae) are also cost-effective oral encapsulation methods and non-pathogenic, conferring survival rates between 62% and 100% post-WSSV challenge [82,89,93,97,98,99,101,102,103,104,111]. Silkworm expression platforms in B. mori have also facilitated oral immunization of VP28 and VP19, generating higher survival rates in crayfish (96.5%) and shrimp (VP19: 45%) compared to E. coli expression of VP19 (27%) in shrimp [72,91,92].
4.1.3. Host-Specific Proteins
Fortilin is a host-derived shrimp protein markedly upregulated during WSSV infections in P. monodon [112]. Initial priming studies employing fortilin explored both intramuscular and oral delivery to assess protection efficacy against WSSV in P. monodon shrimp [113]. Combined oral and injection administration conferred absolute protection, while single delivery methods conferred reduced efficacy, with minimal protection observed for oral delivery (10%) compared to injection (90%) (Table 3). Conversely, oral delivery of fortilin expressed in P. pastoris yeast (5% inclusion) achieved substantial protection in L. vannamei against WSSV (91%), though efficacy was markedly lower against yellow head virus (>20%) [114]. Similarly, an antiviral protein isolated from P. monodon also conferred moderate protection (66.7%) when administered by intramuscular injection [115].
Table 3.
Host-protein-based immunostimulants in crustaceans in immune priming experiments.
Rab7 is another protein of eukaryotes, which has small GTPases involved in endosomal trafficking and phagocytosis [119,120,121] and is upregulated in WSSV-resistant P. japonicus or L. vannamei shrimp. Recombinant Rab7 isolated from P. monodon provided high survival (85%) when intramuscularly injected in L. vannamei challenged with WSSV [116]. Expression of Rab7 in Arabidopsis thaliana T87 cells, a cost-effective plant-based production platform, with crude extracts co-injected with WSSV, yielded 87% survival [117]. Oral delivery of Rab7 expressed and surface-displayed in P. pastoris for 7 days prior to WSSV challenge provided moderate protection, with survival rates of 26.7% and 46.7% at dosages of 0.25 g/g and 0.5 g/g feed, respectively [118]. To date, no studies have explored protein-based immunostimulants in molluscs, let alone those derived from pathogen structural proteins, with current efforts remaining nascent and primarily directed toward elucidating host–pathogen interactions rather than immune protection.
4.2. RNA
Nonspecific Double-Stranded RNA (dsRNA)
Double-stranded RNA (dsRNA) represents a well-established viral mimic capable of eliciting potent antiviral and inflammatory immune responses [122]. During viral infection, dsRNA accumulates and activates PRRs, such as retinoic acid-inducible gene I-like receptors (RIG-I) and TLR3, which induce type I interferons (IFNα, IFNβ, IFNω, IFNε, or IFNκ) and pro-inflammatory cytokines (IL-6, TNFα, and IL-12) to facilitate viral clearance [123,124,125]. In aquatic invertebrates, dsRNA application has predominantly centred on pathogen-specific RNA interference (RNAi) approaches to silence pathogen genes, thereby preventing infection [126]. Synthetic dsRNA analogues, including Poly(I:C), or non-target dsRNAs, also demonstrate significant immune-protective effects across various aquatic invertebrate species [127,128,129].
The use of nonspecific dsRNA as an antiviral immunostimulant in crustaceans was first demonstrated by Robalino et al. (2004), whereby various dsRNAs synthesised from immunoglobulins (duck and pig), noncoding genomic DNA (fish), bacterial vector (pBeloBAC11), and synthetic analogues such as Poly(C–G) and Poly(I:C) were evaluated against WSSV in L. vannamei [128]. Most nonspecific dsRNAs significantly reduced viral mortality except Poly(I:C), which failed to confer protection. Histopathological analysis confirmed the absence of viral inclusions and preservation of tissue integrity in dsRNA-primed shrimp 36–72 h post infection [128] (Table 4).
Table 4.
dsRNA immunostimulants utilised in crustacean and mollusc immune priming experiments.
Building on this, Labreuche et al. (2010) investigated the role of dsRNA length in antiviral protection, using duck immunoglobulin dsRNAs of varying lengths [130]. Longer fragments (200 bp) significantly reduced mortality, while shorter fragments (150 and 100 bp) highly upregulated systemic interference defective 1 (Sid-1) and Argonaute 2 (Ago2) [130]. Sid-1 mediates dsRNA uptake and transport, whereas Ago2 functions in RNA interference and microRNA processing, implying a length-dependent modulation of antiviral pathways. In M. japonicus, exposure to GFP dsRNA enhanced survival following WSSV challenge and upregulated immune genes ((C-type lectin 2, hemocyte homeostasis-associated protein (HAAP), viral responsive protein 15 (VSP15), fibrinogen-related protein 1 (FREP1), and Dicer and Heat shock protein 90 (HSP90)) [131,137]. C-type lectin 2 and FREP1 bind to VP28, inhibiting infection and replication [138,139]. HAAP promotes hemocyte stability [140], and VSP15 is implicated in WSSV recognition and replication [141].
Dual immunostimulant strategies combining Poly(I:C) with rVP28 or the TLR7/8 agonist imiquimod [142] were tested in M. japonicus, yielding survival rates of 52% and 58%, respectively, compared to 43.3% and 37.9% for single-agent treatments [132]. Dual priming significantly upregulated immune effectors, including Rab7, toll, and TNF, with AMPs (lysozyme, penaeidin, and crustin). Similar upregulation of AMPs and Rab7 has been observed following oral rVP28 administration in intestinal and lymphoid organ tissues [86,116,143]. While in mammals, imiquimod is known to induce cytokines, such as IFNα, IL-12, and TNFα [144], consistent with the cytokine profile observed in shrimp treated with imiquimod.
In molluscs, Poly(I:C) has demonstrated potent antiviral activity against OsHV-1 in C. gigas exhibited by near-complete protection, with viral DNA detected in only one of nine oysters [127]. Poly(I:C) induced the upregulation of several antiviral genes MyD88 and IRF, alongside vertebrate interferon-stimulated homologs protein kinase R (PKR) and interferon-induced protein 44 (IFI44). In oysters, IFI44 is upregulated by viral infections, while PKR is an inhibitor of viral and cellular protein synthesis within vertebrate immunology [145,146]. Additional induction of Mpeg1 suggested enhanced cellular antiviral defence via lytic activity against infected cells [146]. Additionally, heat-inactivated Vibrio splendidus failed to protect oysters from OsHV-1, while Poly(I:C) also provided no protection from bacterial Vibrio tasmaniensis for trans-generationally primed oyster larvae, highlighting the specific antiviral nature of Poly(I:C)-induced responses [127,133,134].
Sublethal and inactivated OsHV-1 exposures offered partial protection (26.7% and 12.8% mortality), presumably through recognition of viral dsDNA, but still far below the 100% survival achieved with Poly(I:C) [135]. Long-term Poly(I:C)-induced protection persisting for up to 156 days post challenge has been reported in both laboratory and field conditions [133]. Poly(I:C)-treated oysters exhibited sustained upregulation of immune pathways, including IFN, TLR, NF-κB, Jak/Stat, and apoptosis signalling [50], indicating prolonged antiviral readiness.
Additionally, Poly(I:C) has demonstrated similar protection rates when administered by intra-haemolymph injection of Australian adult abalone hybrid species (Haliotis laevigata × Haliotis rubra) against Haliotid herpesvirus 1 (HaHV-1) [136]. This method of immune primer delivery through intramuscular injection was not as effective as immune primer delivery injected directly within the haemolymph. Similarly to oysters, this protection was long term, with abalone primed at both 16 and 126 days prior to viral challenge, exhibiting high survival rates. TGIP has also been shown to further extend Poly(I:C)’s protective effects in molluscs for antiviral defence, as offspring from maternally primed oysters exhibited markedly reduced OsHV-1 DNA loads and lower mortality compared to paternal priming [59,60]. The transfer of antiviral transcripts such as Viperin and IRF to eggs and larvae underscores the potential for Poly(I:C)-induced TGIP in oyster populations.
4.3. DNA
4.3.1. Flagellin
In Cho et al. (2017), the fusion of WSSV proteins, VP28 and VP19 with flagellin 2 derived from Salmonella typhimurium in an orally administered bivalent DNA vaccine enhanced efficacy against WSSV in Macrobrachium nipponense and Palaemon paucidens shrimp [71]. The inclusion of flagellin increased survival rates by >10% relative to monovalent formulations. Without flagellin, these bivalent DNA constructs demonstrated high efficacy (<80%), depending on the gene sequence order, where VP19 preceding VP28 produced somewhat lower mortality. When flagellin was incorporated, mortality decreased further to 15.8% (VP19 first) and 10.5% (VP28 first), indicating the host immune response was likely mediated through elevated NF-kB activation via several TLRs [71] (Table 5).
Table 5.
DNA-based immunostimulants utilised in crustacean immune priming experiments.
4.3.2. CPG ODNS
CpG oligodeoxynucleotides (ODNs) represent unmethylated cytosine-guanine motifs derived from bacterial DNA that act as potent immunostimulants through TLR9 recognition [160,161]. In crustaceans, CpG administration has been shown to augment immune enzymatic activities, manifested through increased lysozyme, phenoloxidase (PO), and reactive oxygen species (ROS) activity within haemocytes [147,162,163,164,165], with comparable responses also reported in bivalves such as mussels [166].
Experimental investigations into the antiviral efficacy of CpG ODNs have revealed transient protection with injection of tandem CpG ODNs in L. vannamei delaying and only modestly reducing mortality 14 days post-WSSV challenge [147] (Table 5). In contrast, dietary supplementation further reduced viral burden by approximately 3.5-fold, accompanied by significant induction of PO, nitric oxide (NO), and key antiviral mediators such as Stat and Dicer [148]. Comparative analyses of structurally distinct CpG types (A, B, C, and P) identified type A as eliciting the strongest antiviral response, producing the lowest viral loads and the highest expression of Stat, IRF, Vago4, and IFN [167].
Beyond antiviral applications, CpG ODNs have demonstrated protection against bacterial pathogen Aeromonas hydrophila. In the Chinese mitten crab (Eriocheir sinensis), dietary inclusion of CpG conferred a 10% reduction in mortality upon challenge, while also promoting growth performance and a dose-dependent increase in lysozyme activity, indicative of enhanced antibacterial immunity [149]. Similarly, in freshwater crayfish (C. quadricarinatus), CpG administration elevated total haemocyte counts (THC), phagocytic index (PI), and lysozyme activity, with CpG ODN 2006 eliciting the most pronounced immunostimulatory effects [168].
4.3.3. Structural Pathogen-Specific DNA
Several WSSV structural proteins have been utilised in DNA vaccines, driven by eukaryotic promoters to facilitate in vivo expression within the host [154,155]. Among the earliest demonstrations of this concept, Rout et al. (2007) reported that intramuscular injection of P. monodon with DNA encoding VP15, VP28, VP35, and VP281 elicited varying degrees of protection following viral challenge [150] (Table 5). Survival rates were highest for VP28 (51%) and VP281 (46%), with combined vaccination of both modestly improving long-term protection at 35 and 50 days post priming. Similarly, Kumar et al. (2008) demonstrated enhanced survival in VP28 DNA-vaccinated shrimp, with elevated antiviral enzyme activities, including proPo and superoxide dismutase (SOD) across multiple tissues (head muscle, hepatopancreas, pleopods, and gut) and timepoints post vaccination (3, 15, and 30 days) [151]. Consistent with these observations, Kono et al. (2010) reported comparable survival rates in M. japonicus injected with VP28 DNA constructs under similar conditions [143].
Subsequent studies have investigated alternative delivery routes to improve vaccine practicality in aquaculture systems. For instance, Cherax clarkii crayfish vaccinated orally with S. typhimurium expressing VP28 DNA exhibited significant protection of 83.3%, 66.7%, and 56.7% at 7, 15, and 25 days post vaccination, respectively [153]. Comparable outcomes were reported when VP28 DNA was encapsulated in chitosan nanoparticles and administered orally to P. monodon [152]. Similar results were also documented in Scylla serrata crabs orally immunised with VP28 DNA encapsulated in chitosan/tripolyphosphate nanoparticles [156]. Moreover, Mu et al. (2012) evaluated both oral and injection delivery of VP28 DNA plasmid in P. clarkii, with both administration routes eliciting high protection [157]. DNA vaccine efficacy has also been demonstrated in the giant freshwater prawn Macrobrachium rosenbergii against white tail disease (WTD), where encapsulation of nodavirus small virus antisense (XSVAS) DNA within chitosan nanoparticles yielded moderate survival improvements via immersion and oral delivery [158]. A later study utilising the WTD capsid gene DNA achieved markedly enhanced protection, with survival peaking at 80% 40 days post vaccination [159]. However, if mortality was assessed for longer than 10 days, until the 20 days reported by [158] survival rates may appear more similar.
4.3.4. Host-Specific DNA
To date, only one study in P. monodon shrimp utilised host-specific DNA in vaccine work. Pathan et al. (2013) identified that the antiviral host protein (PmAV) derived from P. monodon when encapsulated in chitosan provided the highest protection (83.3%) compared to naked PmAV plasmid (27.8%) against WSSV [115] (Table 5). The authors concluded that the chitosan nanoparticles provided higher stability with naked DNA more prone to degradation by nucleases present in the host.
4.4. Carbohydrates
4.4.1. β-Glucan
β-glucans are poly-glucopyranoses featuring β-(1,3)-D linkages along their backbone, often with β-(1,6)-linked side branches, the degree and pattern of which determine their immunomodulatory properties [169]. As PAMPs, β-glucans engage PRRs to activate innate immune pathways, enhancing phagocytic activity (PA), lysozyme production, complement activation, and cytokine expression [169]. Early trials in P. monodon indicated variable protection against WSSV, with survival improving from 0–15% in juvenile shrimp and 18.3–31.6% in post-larval shrimp post-WSSV challenge following optimal β-1,3-glucan supplementation [170,171] (Table 6). Similar studies in brown (Farfantepenaeus californiensis) and Indian shrimp (Fennerpenaeus indicus) reported delayed or decreased mortality and elevated antioxidant enzyme activity and immunity with THC, total plasma protein (TPP), and PA following β-glucan administration [172,173].
Table 6.
β-glucan-based immunostimulants utilised in crustacean and molluscan immune priming experiments.
β-glucan efficacy is strongly influenced by environmental conditions and glucan structure. Synergistic effects of higher temperature combined with β-glucan supplementation enhanced antiviral protection in L. vannamei against WSSV [197]. Modified water-soluble forms such as carboxymethyl-glucan (CMG), sulfoethyl-glucan (SEG), and γ-irradiated β-glucans induced stronger immune activation and reduced WSSV mortality compared to unmodified forms [177,178].
Marine yeast-derived glucans, notably from Candida sake and Debaryomyces hansenii, conferred survival benefits ranging from 37% to 70% following WSSV challenge in shrimp, accompanied by increased THC, respiratory burst, and AMP expression [176,179,180]. However, other glucans from Wickerhamomyces anomalus, Candida glabrata, Candida haemulonii, and C. sake have also reported increased viral susceptibility, highlighting the protective potential of β-glucans with molecular weight and branching [174,175,179]. Marine yeasts, Yarrowia lipolytica and D. hansenii, contain high concentrations of β-glucan and demonstrate bactericidal activity against Vibrio parahaemolyticus, significantly upregulating immune gene expression and enzymatic defences in L. vannamei [181,198].
Additional sources such as diatoms-derived glucans (Chaetoceros muelleri) and commercial preparations derived from S. cerevisiae with the addition of chitin also confer strong disease resistance, with survival rates exceeding 80% in P. merguiensis and Artemia spp. against V. campbelli and V. proteolyticus [182,183,184]. Additionally, other important Vibrio spp. have been utilised in β-glucan challenges, with enhanced immunity and survival against Vibrio spp. across multiple crustacean species when β-glucans were delivered either by immersion or feed prior to challenge [185,186,187,190,192]. β-glucan dietary supplementation has been shown to enhance M. rosenbergii immunity with elevated THC, PO, and proPo activity and survival following A. hydrophila [188,189] and WTD challenge [199]. Additionally, an early study demonstrated maternal priming with β-1,3-1,6-glucan derived from baker’s yeast (S. cerevisiae) conferred protection and overall reduction of clinical symptoms in P. monodon offspring following WSSV challenge [55].
In oysters, C. gigas fed algae diets supplemented with S. cerevisiae Δmnn9 mutant-improved survival post-Vibrio coralliilyticus challenge, an effect associated with heightened transcription of key immune effectors, including lysozyme, SOD, MyD88, NFκB, and β-glucan binding protein (βGBP) [193]. Many of these genes have been shown to be upregulated in response to β-glucan stimulation in other molluscs and crustaceans, such as Perna viridis [200], Artemia franciscana [191,194], F. chinensis [201], Ruditapes philippinarum [202], Chlamys farreri [203], and in previous work on C. gigas and Ostrea edulis [204,205,206].
Complementary findings were reported in oysters and fed diets composed of β-glucans extracted from mushrooms, whereby immunity was significantly enhanced and complete survival obtained against Escherichia spp. and Vibrio spp. 48 h post challenge [195]. In Taiwanese abalone (Haliotis diversicolor supertexta), in vivo administration of β-1,3/1,6-glucan significantly enhanced THC, respiratory burst, PO activity, PI, and phagocytic rate (PR), while also improving survival following Vibrio alginolyticus challenge [196]. This protection was attributed to β-glucan-induced activation of nonspecific immune mechanisms. Despite these encouraging findings, the application of β-glucans as immunostimulants in molluscan pathogen-challenge studies remains comparatively underdeveloped.
4.4.2. Peptidoglycan
Peptidoglycan (PGN), a fundamental structural component of bacterial cells, is readily perceived by PRRs, provoking a suite of innate immune responses, including macrophage activation and induction of cytokines, such as IL-1, IL-6, and TNF-α [207,208,209]. Within aquatic organisms, PGN has emerged as an immunomodulator, frequently utilised to delineate host–pathogen interactions and innate immune mechanisms [210,211,212,213,214]. Dietary PGN sourced from Bifidobacterium thermophilum (0.2–0.4 mg/kg/day) elicited dramatic improvements in survival for P. japonicus shrimp, with some feeding regimens achieving complete long-term protection [215] (Table 7). Similar dietary interventions in L. vannamei of PGN at higher concentrations (25 mg/kg) and over longer periods (8 weeks) increased survival and elevated pivotal immune enzyme activities, including SOD, PO, CAT, lysozyme, acid phosphatase (ACP), and alkaline phosphatase (AKP), while upregulating immune-related genes [216].
Table 7.
Peptidoglycan-based immunostimulants utilised in crustacean immune priming experiments.
The integration of PGN with other functional feed additives, particularly mannan oligosaccharides (MOS), has revealed synergistic effects on growth performance, immune activation, and overall physiological homeostasis. Supplementation of P. monodon diets with combined PGN and MOS over an 8-week period notably enhanced weight gain and survival against WSSV, with the most pronounced effects at 0.2% inclusion accompanied by increased as THC and respiratory burst activity [217]. Comparable outcomes have been reported across diverse crustacean species, including shrimp, crabs, crayfish, and lobsters further substantiating the broad applicability of PGN-based immunostimulants in aquaculture [214,218,219,220,221,222,223].
Further pathogen challenge studies reinforce PGN’s immune-potentiating capacity with extended feeding of P. japonicus shrimp, with PGN demonstrating markedly increased survivorship following Vibrio penaeicida exposure [215]. Complementary studies indicate that dietary PGN at 5 mg/kg confers resistance to Vibrio parahaemolyticus, accompanied by coordinated upregulation of immune enzymes and signalling pathways consistent with earlier findings [216]. To date, no studies have directly tested PGN as an immunostimulant in molluscan pathogen-challenge experiments, with the explicit aim of enhancing host survival or resistance. Nevertheless, extensive evidence suggests that molluscs possess the cellular and molecular machinery to detect and respond to PGN, through peptidoglycan recognition protein (PGRP) family, which has been identified in scallops [224], clams [225,226,227,228,229], mussels [230,231], periwinkles [232], abalone [233], and oysters [234,235,236,237]. In these species, PGRPs are frequently localised within immunologically active tissue, such as the hepatopancreas [227,228,229,230,236], haemocytes [224,229,231,234,235,236], gill [226,228,230,231,234,236], and digestive gland [231,234], and are typically unregulated following bacterial challenge [224,225,226,227,229,230,231,233,235,236]. Furthermore, characterised PGRPs exhibit differential binding affinities for PGN and lipopolysaccharide (LPS) and yeast-derived components such as β-glucans [224,227,228,229,230,233,236], underscoring their functional versatility in recognising a spectrum of microbial elicitors.
Although no direct evidence demonstrates PGN-mediated protection against aquatic pathogens in molluscs, the widespread presence, inducibility, and ligand-binding competence of PGRPs strongly suggest that PGN-based immune-stimulation may confer at protective benefits in molluscs, providing a strong foundation for future investigations into PGN-driven immune priming in molluscs.
4.4.3. Lipopolysaccharide
Lipopolysaccharides (LPS) are major components of Gram-negative bacterial outer membranes and are recognised as PAMPs by TLR4, initiating a cascade of innate immune signalling events that culminate in inflammation-associated pathogen neutralisation [238,239,240]. Early foundational studies in horseshoe crab (Tachypleus tridentatus) identified LPS-binding proteins capable of detecting LPS and inducing robust innate immune activities [241,242] with comparable LPS-elicited responses characterised in abalone [243,244], oysters [245,246,247], clams [64], and shrimp [248,249]. However, LPS is not uniformly immunostimulatory; excessive or prolonged stimulation may suppress immune function through dose-dependent downregulation of key immune genes [250]. Although LPS research in aquatic invertebrates has largely focused on elucidating fundamental host–pathogen interactions, several studies demonstrate dietary or injected LPS can enhance antiviral and antibacterial resistance in penaeid shrimp. Dietary supplementation with Vibrio harveyi–derived LPS resulted in dose-dependent improvement in survival of post-larval (P. monodon) shrimp against WSSV; however, concentrations exceeding 50 mg kg−1 or extending feeding prior to challenge reduced survival rates [251,252] (Table 8).
Table 8.
Lipopolysaccharide-based immunostimulants utilised in crustacean immune priming experiments.
Oral administration of LPS derived from Pantoea agglomerans enhanced immunity in P. japonicus, with lower doses providing better protection against penaeid acute viraemia (PAV), underscoring the dose-dependent balance between immune priming and immune exhaustion [255].
Beyond viral interactions, LPS has also been shown to improve bacterial resistance in juvenile P. monodon shrimp, with intermediate dietary levels enhancing survival following V. parahaemolyticus challenge and maximised PO activity [256]. In L. vannamei, low to moderate LPS inclusion (0.2–1 mg kg−1) improved growth, immune enzyme activity, and survival against both WSSV and V. parahaemolyticus, whereas high concentrations suppressed ACP and AKP activity. Transcriptomic analyses indicate LPS modulates complex cellular processes and innate immunity pathways, including phosphatidylinositol, Wnt, and Jak-Stat signalling, suggesting broad immunomodulatory effects [257].
Dietary LPS also enhances protection against V. harveyi, with P. monodon shrimp fed V. harveyi-derived LPS displaying markedly increased survival, elevated PA, antibacterial activity, and respiratory burst, similar to results reported in other studies [250,254,258,259]. Consistent results were achieved for both injection vs. immersion-based challenge models, indicating that LPS-mediated immune stimulation is robust across different infection routes, regardless of feeding frequency [254,260]. LPS origin furthers influences immunostimulatory potency with E. coli-derived LPS inducing stronger immune activation and greater protection than V. harveyi-derived LPS against V. harveyi. Dose-dependent patterns were observed in high doses of V. harveyi-derived LPS, suggesting induced immune suppression, whereas higher doses of E. coli-derived LPS remained beneficial [253].
As previously mentioned, LPS stimulation has not been applied to pathogen-challenge immune priming experiments, despite haemocytes of mussels [261,262], abalone [243,244], and oysters [245,247] exhibit robust LPS-induced immune responses, including the upregulation of immune-related genes and increased effector activities. These findings demonstrate that molluscs possess the necessary cellular machinery for LPS recognition and sustained activation, providing a mechanistic basis for future LPS-focused immune priming studies.
4.5. Whole Cell
Whole-cell vaccines, derived from inactivated bacterial or viral pathogens, have long been central to studying invertebrate immunity and developing disease mitigation strategies. Their efficacy stems from the presentation of a highly complex assembly of PAMPs, including PGNs, LPS, flagellins, and nucleic acids that mimic natural infection, while regarded as safe for administration. Across crustaceans and molluscs, whole-cell preparations consistently enhance cellular immune functions and confer increased survival upon pathogen re-exposure.
In crustaceans, whole-cell vaccination represents one of the most extensively investigated immune priming approaches (Table 9). Early investigations in penaeid shrimp employed inactivated Vibrio spp. to augment antibacterial immune responses [263] and improve survival following pathogenic challenge [264,265,266]. Building upon these early observations, commercial multivalent vaccine AquaVac™ Vibromax™, comprising of formalin-inactivated V. anguillarum, V. ordalii, V. harveyi, V. parahaemolyticus, and V. vulnificus, demonstrated substantial protective efficacy when administered orally via enriched A. nauplii in P. monodon and L. vannamei shrimp [267]. This multivalent vaccine reduced bacterial loads, increased survival against V. parahaemolyticus, and improved overall health. However, a follow-up study revealed variable efficacy across Vibrio species, with limited protection observed against V. harveyi, potentially due to confounding nutritional effects during challenge experiments [268].
Table 9.
Whole cell-based immunostimulants utilised in crustacean immune priming experiments.
Comparable broad-spectrum protection has also been reported in banana shrimp (F. merguiensis), where oral administration of inactivated V. anguillarum conferred cross-protection against both V. anguillarum and V. harveyi, yielding marginally higher protection (10%) against the homologous pathogen challenges [280]. Whole-cell vaccination did not impair growth, as vaccinated shrimp exhibited increased carcass lipid and protein content, reinforcing the suitability of such strategies for aquaculture applications [268,280].
Pathogen inactivation methods strongly influence vaccine efficacy. Formalin-inactivated V. alginolyticus provided longer-lasting protection due to improved preservation of antigenic epitopes, whereas heat inactivation may promote excessive LPS release and epitope denaturation, exhibiting a shorter immune response that resulted in higher mortalities [275]. Nevertheless, contradictory findings have reported heat-inactivated V. alginolyticus eliciting higher survival rates compared to formalin-inactivated preparations [276]. To address these inconsistencies, combined vaccines incorporating both heat- and formalin-inactivated V. harveyi and V. alginolyticus demonstrated significantly enhanced survival following live challenge, albeit with consistently higher protection against V. alginolyticus than V. harveyi [281].
In the Chinese mitten crab (E. sinensis), formalin-inactivated A. hydrophila significantly enhanced survival following homologous challenge, increasing cellular immunity [277]. Mud crab (Scylla paramamosain) primed with heat-killed V. parahaemolyticus also exhibited enhanced survival and upregulation of immune genes, along with strong down syndrome cell adhesion molecule (Dscam) expression upon V. parahaemolyticus challenge [278]. Dscam upregulation was also reported in A. hydrophila-primed crabs, supporting its proposed role in pathogen recognition and clearance within invertebrates [277,278]. Formalin-inactivated V. parahaemolyticus conferred marginally higher survival than heat-inactivated preparations, though immune responses (PO activity) were sometimes transient [277,279].
Early studies in whole-cell priming utilizing viral pathogens revealed increased WSSV resistance in shrimp following viral re-exposure was attributable to immune priming, rather than genetic selection with plasma from previously exposed individuals exhibiting viral neutralisation capacity [269,270,271]. Housing conditions influenced priming efficacy, with animals housed together conferring superior resistance than animals housed alone [269]. In crayfish (P. clarkii), binary ethylenimine (BEI)-inactivated WSSV significantly improved survival, whereas heat-inactivated virus failed to confer protection, likely due to capsid protein denaturation, essential for immune recognition [272]. Oral delivery trials confirmed that BEI and formalin-inactivation preserve viral structural integrity, eliciting robust immune priming responses [276,280]. Similar, albeit less pronounced, inactivation-dependent effects have been reported for bacterial vaccines in shrimp [272,275].
Delivery route of whole-cell vaccines has been shown to impact efficacy. Immersion priming, particularly using freeze-dried or freshly prepared V. harveyi, provided short-term protection against V. harveyi in P. indicus shrimp [264], while spray vaccination and injection yielded comparable survival outcomes in P. japonicus prawns against V. vulnificus [265]. Timing between priming and challenge, as well as co-administration with immunostimulants such as β-glucans, further enhanced long-term protection [75,266,274]. Collectively, vaccine efficacy depends greatly on the structural integrity maintained throughout inactivation processes [75,272,273].
Whole-cell vaccination strategies in molluscs remain comparatively underexplored relative to crustaceans; however, studies suggest that molluscs exhibit robust pathogen resistance (Table 10). Heat-killed V. splendidus in oysters enhanced haemocyte activity, notably phagocytosis in a pathogen-specific manner [282]. Immersion of oysters in low concentrations of formalin-inactivated V. alginolyticus resulted in exceptionally high survival (100% and 92.5%), whereas priming with live V. alginolyticus at equivalent doses resulted in strong inflammatory responses and accelerated mortality [57]. These contrasting outcomes reflect differences in ROS-mediated production, whereby live bacteria induced excessive inflammatory responses and tissue damage and inactivated bacteria elicited a controlled protective oxidative response [57,283,284].
Table 10.
Whole cell-based immunostimulants utilised in molluscan immune priming experiments.
Whole-cell priming has been extensively investigated for OsHV-1 in C. gigas. Field observations demonstrated that adult oysters previously exposed to OsHV-1 exhibited markedly increased survival upon rechallenge (90.2%) compared to naïve spat or adults (16.7% and 8.3%, respectively) and carried reduced viral loads [297]. Experimental work confirms non-lethal OsHV-1 exposure at 18 °C enhances resistance upon viral challenge at 22 °C, highlighting the synergistic relationship between temperature and viral susceptibility for OsHV-1 [296]. Live and heat-inactivated OsHV-1 conferred substantial (81.2% and 73.3%) protection, though Poly(I:C) consistently provides the highest survival (100%) [283]. Ultraviolet (UV)-inactivated OsHV-1 achieved protection levels comparable to Poly(I:C) (97–100%), with long-lasting immunity persisting over 3 months post priming, supported by upregulation of interferon-like and NF-κB-associated antiviral pathways, including RLRs, MyD88, IRFs, and viperin [284].
In scallops (C. farreri), both live and inactivated bacteria induce strong innate immune activation exhibited through phagocytosis, enzymatic activity, and PRRs activation with markedly improved survival upon re-exposure [285,286]. Manila clams (R. philippinarum) also exhibit enhanced AMP expression, immune enzyme activity, PRR signalling, and overall survival following secondary live or inactivated V. anguillarum challenge [290]. These findings closely parallel the protective effects observed in oysters and reinforce the efficacy of whole-cell-induced protection across bivalves [282,286].
In gastropods, particularly abalone, whole-cell priming and natural re-exposure studies provide compelling evidence for long-term immune enhancement. European abalone (Haliotis tuberculata) from the Saint-Malo region of Brittany, which experiences recurrent V. harveyi outbreaks, exhibit elevated survival and enhanced phagocytic capacity 2 months post challenge, along with significantly reduced bacterial loads in the gills, implying coordinated mucosal and systemic protection [289]. This resistance has been attributed to haemolymph AMPs and hemocyanins, which inhibit systemic bacterial growth and transmission [299,300], with reduced bacterial loads associated with localised mechanisms that impair bacterial attachment and lysozyme-mediated pathogen clearance [301,302].
Additional studies report reduced mortality and strong transcriptional responses (e.g., ferritin, heat shock protein HSP84, and fatty acid binding protein) upon secondary V. harveyi exposure [288]. Dose-dependent priming effects have been demonstrated in small abalone (H. diversicolor), with intermediate doses of live V. harveyi providing optimal protection upon secondary challenge [294]. Transcriptomic analyses revealed upregulation of PRRs, immune effector pathways associated with phagocytosis, calcium signalling, and metabolic regulation involved in pathogen defence and clearance. Similar immune responses were observed in Japanese disc abalone (Haliotis discus hannai) following priming with live V. parahaemolyticus, with activation of PRRs (TLRs and RIG-I), NF-κB, TNF, and MAPK signalling pathways within haemocytes [289,294,295,299,300].
Probiotic-based whole-cell exposure also enhances growth and disease resistance in abalone. Probiotics isolated from the gastrointestinal tract of African abalone (Haliotis midae) significantly enhanced growth and survival with elevated haemocyte THC and PA during V. anguillarum challenge [290]. Non-virulent Shewanella species isolated from H. discus hannai gastrointestinal tract improved survival and both cellular and humoral immunity when incorporated into feed [291], likely via mechanisms, such as quorum sensing, melanin secretion, and other antibacterial characteristics [303,304,305]. Prolonged probiotic feeding has similarly reduced pathogen loads and conferred sustained protection against Vibrio species in Haliotis iris and Haliotis rufescens [292,293,306]. Collectively, these findings support persistent, nonspecific immune stimulation through whole-cell or probiotic exposure, consistent with immune priming theory in invertebrates [32].
TGIP extends invertebrate immune priming by enabling parental immune experience to enhance offspring disease resistance. Evidence across crustaceans and molluscs demonstrates that exposure to whole-cell bacterial or viral pathogens can enhance disease resistance in offspring, primarily through maternal transfer of immune effectors and epigenetic modifications. TGIP was first reported in Daphnia magna, where maternal exposure to Pasteuria ramosa resulted in strain-specific enhancement of offspring fitness and survival [52]. Artemia species have since become key TGIP models due to their short generation times. In A. nauplii, maternal priming with V. campbellii significantly improved survival across F1–F3 generations following homologous challenge, although this protection declined with successive generations from 40% improvement in F1, 70% in F2, and to ~20% in F3, indicating progressive dilution of inherited immunity [307] (Table 11). Similar multigenerational species-specific protection was observed in A. franciscana offspring following whole-cell priming with Vibrio species, whereas heterologous challenges yielded substantially reduced protection [308]. Enhanced resistance in F1 and F2 generations was associated with elevated expression of heat shock protein 70 (HSP70) and high mobility group box 1 (HMGB1) [309]. Importantly, this protection was accompanied by persistent epigenetic signatures, including altered H3 and H4 acetylation and enrichment of H3K4me3 across both parental and offspring generations, suggesting an epigenetic inheritance of immune memory [308].
Table 11.
Whole cell-based immunostimulants utilised in crustacean and molluscan transgenerational immune priming experiments.
Consistent evidence demonstrates parental priming with live or inactivated V. campbellii or V. parahaemolyticus enhances homologous protection across F1–F3 generations, with markedly lower protection during heterologous challenge [310]. This inherited resistance correlates with elevated expression of immune-related genes, including peroxinectin (pxn), proPO, LPS-binding protein, βGBP, hmgb1, and HSP90, alongside epigenetic modifications, including altered H3/H4 acetylation and m6A RNA methylation, reinforcing an epigenetic basis for TGIP [308,310].
TGIP is also well documented in molluscs. In C. farreri, maternal priming with heat-killed V. anguillarum during oocyte maturation increased offspring levels of immune effector proteins, Cu/Zn-SOD activity, and antibacterial capacity, accompanied by significantly reduced mortality following bacterial challenge [56]. These findings were consistent with earlier work in insects, demonstrating that offspring immune competence is strongly influenced by maternal immunological history [53].
In oysters, maternal priming with formalin-inactivated V. alginolyticus significantly enhanced offspring resistance to multiple Vibrio species [57], while V. splendidus exposure during spawning increased egg-associated lysozyme, SOD activity, immune gene expression (TLR2, MACPF, and FBG), and antibacterial activity [58]. Following fertilisation, maternally primed larvae exhibited significantly elevated CAT, lysozyme, and SOD activity, whereas paternally priming only resulted in increased expression of immune genes (galectin, MyD88, and LBP) in offspring, which was also demonstrated in maternally primed offspring. Both parental treatments, however, significantly reduced larval mortality upon V. splendidus challenge [58].
Collectively, these studies demonstrate that whole-cell TGIP operates across multiple molluscan and crustacean species, conferring pathogen and strain-specific protection via maternally transferred immune effectors and heritable epigenetic modifications. Although protection can persist across multiple generations, particularly in rapidly reproducing species such as Artemia, the strength of protection typically declines over time, underscoring the need for further research into mechanisms that support durable, long-term inherited immunity.
5. Challenges to Immune Priming
5.1. Synthesis of Immune Primers
There are several practical, technical, and regulatory constraints associated with immunostimulant synthesis, all of which can influence their efficacy, safety, and reproducibility in invertebrate aquaculture. Many immunostimulants are biologically derived (β-glucan, LPS, PGN, nucleic acids, and whole cell), and differences in organism source, strain, culture conditions, and purification methods can result in substantial batch-to-batch variation in molecular composition and immunostimulatory potency. β-glucan provides a well-studied example of how physicochemical properties governing immunological outcomes, such as solubility, molecular weight, and branching patterns, strongly influence immune activation and protection capacity. Given the limited solubility of β-glucans and associated suboptimal immunoenhancement, chemical and physical modifications (carboxymethylation, sulfoethylation, and γ-irradiation) have been employed to improve solubility and efficacy. Although these modified β-glucans have enhanced antiviral efficacy [177,178], these approaches are costly, require specialised infrastructure, and rely on hazardous reagents, limiting their scalability in aquaculture [311].
Moreover, chemical modification can alter β-glucan structure with unpredictable consequences for immunogenicity [312]. Some modified marine yeast-derived β-glucans enhance WSSV protection, whereas others increase susceptibility [175,176,179], suggesting that immunogenicity depends on molecular weight and structure. Conflicting results across studies highlight the complexity of β-glucan structure and function in immune priming. Recombinant protein vaccines present additional challenges as they require genetically modified production systems, are labour-intensive to manufacture [313], and often elicit weaker immunogenic response than whole-cell formulations, which possess a more complex array of PAMPs. Many immunostimulants, particularly nucleic acids, exhibit chemical or biological instability and degrade rapidly due to fluctuations in pH and nucleases [314]. To address this, encapsulation techniques, including nanoparticle-based delivery systems (chitosan, liposomes, and virus-like particles), are increasingly employed to enhance the stability and delivery. However, these encapsulation methods present their own challenges in scalability, short half-lives, high cost, and impracticability in oral delivery [314].
5.2. Administration
Immune priming strategies in molluscs and crustaceans are constrained by both biological and logistical challenges in administration. Injection remains the most experimentally robust delivery method, offering precise control over dosage, reduced variability in uptake, and direct delivery to target tissues, enabling rapid and strong immune responses [315]. It is also the most effective route for delivering immunostimulants such as poly(I:C) in oysters [127,133,135] and baculovirus-expressed VP28 in crayfish [88]. Despite its experimental advantages, injections are inherently labour-intensive, are stressful, require skilled personnel, and are fundamentally impractical for large-scale aquaculture.
Immersion offers a more scalable alternative, enabling high-throughput exposure with reduced handling; however, uptake through epithelial surfaces such as gills is highly variable across developmental stages and species, resulting in inconsistent immune activation and efficacy [49]. Oral administration via feed represents the most operationally feasible strategy for large-scale aquaculture, but faces substantial challenges, including degradation of immunostimulants within the digestive tract, variable ingestion rates, and limited bioavailability.
Selecting an administration route should therefore consider logistics and the natural transmission of the target pathogen and the subsequent host–pathogen interactions [316]. Immune priming strategies that mimic natural infection routes may improve immunological relevance and protective outcomes. This principle is exemplified in TGIP studies in Caenorhabditis elegans, where oral exposure to Orsay virus, reflecting the natural route of viral transmission produced heritable antiviral protection in progeny, while injection failed to confer transgenerational protection [317,318]. Similarly, WSSV spreads orally in shrimp, often through cannibalism [319], yet oral or immersion delivery of VP28 generally provides weaker protection than injection of the same antigen. Despite these limitations, immersion and oral-based approaches remain the only practical method for aquaculture, offering scalability and reduced animal handling, and can stimulate both systemic and mucosal immunity.
Recent advances in encapsulation technologies, including algae and nanoparticle formulations, have improved immunostimulant stability, uptake, and efficacy for both immersion and oral delivery routes, offering promising solutions to current delivery constraints [103,152,271,273].
5.3. Toxicity
Optimising dosage and dosing regimes is critical for effective immune priming in molluscs and crustaceans, as both insufficient and excessive doses can paradoxically exacerbate susceptibility to infection. Many immunostimulants have narrow therapeutic windows, with dose-dependent adverse effects reported across multiple immune priming strategies. For instance, recombinant FlaA becomes toxic when administered at doses above 20 µg in shrimp, reducing survival even without WSSV challenge and causing near-total mortality following challenge, highlighting the consequences of excessive immune activation [65].
Comparable dose-dependent effects have been documented for β-glucans, where overdosing or repeated administration can lead to immunosuppression, immune exhaustion, and immune fatigue, where the energetic costs of sustained immune activation outweigh the benefits and ultimately reduce disease resistance [176]. These effects vary with glucan source and structure, as some marine yeast-derived β-glucans have maintained elevated THC and survival rates even after prolonged use [174,179].
Poly(I:C) further illustrates the trade-off between potency and toxicity, inducing strong antiviral responses and high survival in oysters [59,127,133,282,320]. Yet its documented toxicity at high concentrations in vertebrates, such as that observed in rhesus monkeys (30 mg kg−1) and beagles (5 mg kg−1) [321,322,323], raises safety and regulatory concerns for aquaculture use. In contrast, inactivated OsHV-1 provides lower protection but is considered more acceptable by regulatory authorities.
Collectively, these findings emphasise the necessity for rigorous optimisation of dosage and frequency to balance efficacy while avoiding immunopathology, metabolic burden, and fitness costs.
5.4. Fitness Costs
Immune priming in invertebrates can enhance pathogen resistance; however, the initiation and maintenance are inherently metabolically costly, often imposing significant fitness costs to maintain [44,134,324]. The mechanisms underpinning the persistence of long-term immune enhancement remain not fully elucidated across and between species despite increasing empirical evidence for both immune priming and TGIP [325]. A clear example of these trade-offs occurs in the Peruvian calico scallop Argopecten purpuratus, where V. splendidus challenge revealed a pronounced trade-off between reproduction and immune defense [320]. Following spawning, scallops exhibited marked reductions in haemocyte abundance, protein content, metabolic rate, respiratory activity, and immunological activity, reflecting that the energetic costs of reproduction constrain immune competence.
Fitness costs have also been associated with TGIP, where sustained immune activation or parental investment in immune defence can negatively impact fecundity, growth rates, lifespan, and reproductive ability [326,327,328,329,330,331,332]. Such trade-offs suggest that enhanced offspring immunity may come at the expense of parental condition, influencing the evolutionary stability of TGIP. Inconsistencies reported in TGIP outcomes may therefore reflect differences in experimental design, biological context, or publication bias favouring positive findings [333]. In molluscs, these trade-offs are particularly evident. In oysters, maternal poly(I:C) priming increased larval survival against OsHV-1; however, simultaneously reduced larval growth altered the microbiome and increased opportunistic Vibrio species abundance [142]. These findings highlight that while immune priming and TGIP can provide short-term protection, their metabolic and fitness costs constrain long-term application, particularly in aquaculture, where rapid growth and reproductive output are critical.
6. Conclusions
In summary, immunostimulants represent a promising and environmentally sustainable approach for enhancing disease resistance in molluscan and crustacean aquaculture, owing to their capacity to activate innate immune defences in a broad or pathogen-specific manner while remaining biodegradable and generally safe for human consumption. Experimental evidence demonstrates that immunostimulant-mediated immune priming can reduce pathogen burden, enhance immune activation, and improve survival following challenge; however, significant barriers to commercial translation remain. These include constraints surrounding synthesis, administration, dose-dependent toxicity, and fitness costs linked to sustained immune activation. Although advances such as chemical modification, encapsulation technologies, and dosage optimisation have improved efficacy and delivery, further research is required to elucidate the mechanistic basis of immune priming in non-model aquaculture species and to evaluate the durability and long-term consequences of protection. Addressing these knowledge gaps will be critical for enabling the safe, scalable, and effective integration of immunostimulant-based immune priming strategies into intensive aquaculture production systems.
Author Contributions
Conceptualization, D.A., K.H. and T.B.; data curation, D.A.; writing—original draft preparation, D.A.; figures, D.A. and T.B.; writing—review and editing, D.A., J.A., D.B., K.H. and T.B.; supervision, K.H. and T.B.; funding acquisition, K.H. and T.B. All authors have read and agreed to the published version of the manuscript.
Funding
This work was supported by the project ‘2021-085 Optimizing an immune priming approach to combat HaHV-1 in abalone, awarded to K.J.H. and T.B. with funding provided by the Australian Abalone Growers Association and the Fisheries Research and Development Corporation on behalf of the Australian Government. J.A. and D.A. were supported by La Trobe University Industry PhD scholarships.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
No new data were created or analyzed in this study. Data sharing is not applicable to this article.
Acknowledgments
We wish to acknowledge the members of the Helbig and Beddoe Labs.
Conflicts of Interest
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Abbreviations
The following abbreviations are used in this manuscript:
| TGIP | Trans-generational immune priming |
| AMP | Antimicrobial peptide |
| PAMP | Pathogen-associated molecular pattern |
| PRR | Pathogen recognition receptor |
| dsRNA | Double-stranded ribonucleic acid |
| DNA | Deoxyribonucleic acid |
| CpG ODN | Cytosine-guanine oligodeoxynucleotides |
| PGN | Peptidoglycan |
| LPS | Lipopolysaccharide |
| TLR | Toll-like receptor |
| WSSV | White spot syndrome virus |
| OsHV-1 | Ostreid herpesvirus 1 |
| HaHV-1 | Halliotid herpesvirus 1 |
| WTD | White tail disease |
| proPo | Pro-phenoloxidase |
| PO | Phenoloxidase |
| Poly(I:C) | Polyinosinic-polycytidylic acid |
| THC | Total haemocyte counts |
| SOD | Superoxide dismutase |
| NO | Nitric acid |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| TNF | Tumor necrosis factor |
References
- Nobre, A.M.; Robertson-Andersson, D.; Neori, A.; Sankar, K. Ecological–economic assessment of aquaculture options: Comparison between abalone monoculture and integrated multi-trophic aquaculture of abalone and seaweeds. Aquaculture 2010, 306, 116–126. [Google Scholar] [CrossRef] [Scilit]
- Chang, Y.C.; Ma, C.H.; Lee, H.T.; Hsu, T.H. Polyculture of juvenile dog conch Laevistrombus canarium reveals high potentiality in integrated multitrophic aquaculture (IMTA). Biology 2021, 10, 812. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Murphy, A.E.; Emery, K.A.; Anderson, I.C.; Pace, M.L.; Brush, M.J.; Rheuban, J.E. Quantifying the effects of commercial clam aquaculture on C and N cycling: An integrated ecosystem approach. Estuaries Coasts 2016, 39, 1746–1761. [Google Scholar] [CrossRef] [Scilit]
- Ben-Horin, T.; Burge, C.A.; Bushek, D.; Groner, M.L.; Proestou, D.A.; Huey, L.I.; Gidegain, G.; Carnegie, R.B. Intensive oyster aquaculture can reduce disease impacts on sympatric wild oysters. Aquac. Environ. Interact. 2018, 10, 557–567. [Google Scholar] [CrossRef] [Scilit]
- Cranford, P.J.; Strain, P.M.; Dowd, M.; Hargrave, B.T.; Grant, J.; Archambault, M.C. Influence of mussel aquaculture on nitrogen dynamics in a nutrient enriched coastal embayment. Mar. Ecol. Prog. Ser. 2007, 347, 61–78. [Google Scholar] [CrossRef] [Scilit]
- Kluger, L.C.; Taylor, M.H.; Wolff, M.; Stotz, W.; Mendo, J. From an open-access fishery to a regulated aquaculture business: The case of the most important Latin American bay scallop (Argopecten purpuratus). Rev. Aquac. 2019, 11, 187–203. [Google Scholar] [CrossRef] [Scilit]
- Yurimoto, T.; Mohd Kassim, F.; Fuseya, R.; Man, A. Mass mortality event of the blood cockle, Anadara granosa, in aquaculture ground along Selangor coast, Peninsular Malaysia. Int. Aquat. Res. 2014, 6, 177–186. [Google Scholar] [CrossRef] [Scilit]
- Jayanthi, M.; Thirumurthy, S.; Muralidhar, M.; Ravichandran, P. Impact of shrimp aquaculture development on important ecosystems in India. Glob. Environ. Change 2018, 52, 10–21. [Google Scholar] [CrossRef] [Scilit]
- Hoover, C.M.; Sokolow, S.H.; Kemp, J.; Sanchirico, J.N.; Lund, A.J.; Jones, I.J.; Higginson, T.; Riveau, G.; Savaya, A.; Coyle, S.; et al. Modelled effects of prawn aquaculture on poverty alleviation and schistosomiasis control. Nat. Sustain. 2019, 2, 611–620. [Google Scholar] [CrossRef] [Scilit]
- Supriyono, E.; Adiyana, K.; Thesiana, L. A Study of Environmentally Friendly Recirculating Aquaculture System on Lobster Panulirus homarus Nursery. Pol. J. Environ. Stud. 2023, 32, 4805–4811. [Google Scholar] [CrossRef] [Scilit]
- Apine, E.; Ramappa, P.; Bhatta, R.; Turner, L.M.; Rodwell, L.D. Challenges and opportunities in achieving sustainable mud crab aquaculture in tropical coastal regions. Ocean Coast. Manag. 2023, 242, 106711. [Google Scholar] [CrossRef] [Scilit]
- FAO. The State of World Fisheries and Aquaculture 2022; FAO: Rome, Italy, 2022. [Google Scholar] [CrossRef] [Scilit]
- Boyd, C.E.; McNevin, A.A.; Davis, R.P. The contribution of fisheries and aquaculture to the global protein supply. Food Secur. 2022, 14, 805–827. [Google Scholar] [CrossRef] [Scilit]
- Kumar, A. Functionality of probiotics on the resistance capacity of shrimp against white spot syndrome virus (WSSV). Fish Shellfish Immunol. 2023, 140, 108942. [Google Scholar] [CrossRef] [Scilit]
- Liao, X.; He, J.; Li, C. Decapod iridescent virus 1: An emerging viral pathogen in aquaculture. Rev. Aquac. 2022, 14, 1779–1789. [Google Scholar] [CrossRef] [Scilit]
- Noble, T.H.; Coman, G.J.; Wade, N.M.; Thomson, P.C.; Raadsma, H.W.; Khatkar, M.S.; Guppy, J.L.; Jerry, D.R. Genetic parameters of Gill-associated virus infection and body weight under commercial conditions in black tiger shrimp, Penaeus monodon. Aquaculture 2020, 528, 735580. [Google Scholar] [CrossRef] [Scilit]
- Zhai, S.; Yang, B.; Zhang, F.; Li, Q.; Liu, S. Estimation of genetic parameters for resistance to Vibrio alginolyticus infection in the Pacific oyster (Crassostrea gigas). Aquaculture 2021, 538, 736545. [Google Scholar] [CrossRef] [Scilit]
- Jiang, Q.; Shi, L.; Ke, C.; You, W.; Zhao, J. Identification and characterization of Vibrio harveyi associated with diseased abalone Haliotis diversicolor. Dis. Aquat. Org. 2013, 103, 133–139. [Google Scholar] [CrossRef] [Scilit]
- Chandrakala, N.; Priya, S. Vibriosis in shrimp aquaculture a review. Int. J. Sci. Res. Sci. Eng. Technol. 2017, 3, 27–33. [Google Scholar]
- Vicente, V.A.; Orélis-Ribeiro, R.; Najafzadeh, M.J.; Sun, J.; Guerra, R.S.; Miesch, S.; Ostrensky, A.; Meis, J.F.; Klaassen, C.H.; de Hoog, G.S.; et al. Black yeast-like fungi associated with Lethargic Crab Disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae). Vet. Microbiol. 2012, 158, 109–122. [Google Scholar] [CrossRef] [Scilit]
- Macey, B.M.; Christison, K.W.; Mouton, A. Halioticida noduliformans isolated from cultured abalone (Haliotis midae) in South Africa. Aquaculture 2011, 315, 187–195. [Google Scholar] [CrossRef] [Scilit]
- Brady, D.J.; Meade, R.; Reynolds, J.D.; Vilcinskas, A.; Theissinger, K. The crayfish plague pathogen Aphanomyces astaci in Ireland. Microorganisms 2024, 12, 102. [Google Scholar] [CrossRef] [Scilit]
- Muznebin, F.; Alfaro, A.C.; Webb, S.C. Occurrence of Perkinsus olseni and other parasites in New Zealand black-footed abalone (Haliotis iris). N. Z. J. Mar. Freshw. Res. 2023, 57, 261–281. [Google Scholar] [CrossRef] [Scilit]
- Loker, E.S.; Adema, C.M.; Zhang, S.; Kepler, T.B. Invertebrate Immune Systems—Not Homogeneous, Not Simple, Not Well Understood. Immunol. Rev. 2004, 198, 10–24. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, L.; Qiu, L.; Zhou, Z.; Song, L. Research progress on the mollusc immunity in China. Dev. Comp. Immunol. 2013, 39, 2–10. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rowley, A.F.; Pope, E.C. Vaccines and crustacean aquaculture—A mechanistic exploration. Aquaculture 2012, 334–337, 1–11. [Google Scholar] [CrossRef] [Scilit]
- Smith, V.J.; Brown, J.H.; Hauton, C. Immunostimulation in crustaceans: Does it really protect against infection? Fish Shellfish Immunol. 2003, 15, 71–90. [Google Scholar] [CrossRef] [Scilit]
- Barman, D.; Nen, P.; Mandal, S.C.; Kumar, V. Immunostimulants for aquaculture health management. J. Mar. Sci. Res. Dev. 2013, 3, 134. [Google Scholar] [CrossRef]
- Zhang, L.; Li, L.; Guo, X.; Litman, G.W.; Dishaw, L.J.; Zhang, G. Massive expansion and functional divergence of innate immune genes in a protostome. Sci. Rep. 2015, 5, 8693. [Google Scholar] [CrossRef] [Scilit]
- Wang, W.; Wang, L.; Song, L. The Immune Priming in Aquaculture Invertebrates: Inspiration From Cellular Perspective and Future Investigation. Rev. Aquac. 2024, 17, e12977. [Google Scholar] [CrossRef] [Scilit]
- Tetreau, G.; Dhinaut, J.; Gourbal, B.; Moret, Y. Trans-generational immune priming in invertebrates: Current knowledge and future prospects. Front. Immunol. 2019, 10, 1938. [Google Scholar] [CrossRef] [Scilit]
- Little, T.J.; Kraaijeveld, A.R. Ecological and evolutionary implications of immunological priming in invertebrates. Trends Ecol. Evol. 2004, 19, 58–60. [Google Scholar] [CrossRef] [Scilit]
- Rathinam, R.B.; Acharya, A.; Robina, A.J.; Banu, H.; Tripathi, G. The immune system of marine invertebrates: Earliest adaptation of animals. Comp. Immunol. Rep. 2024, 7, 200163. [Google Scholar] [CrossRef] [Scilit]
- Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Botos, I.; Segal, D.M.; Davies, D.R. The Structural Biology of Toll-Like Receptors. Structure 2011, 19, 447–459. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hibino, T.; Loza-Coll, M.; Messier, C.; Majeske, A.J.; Cohen, A.H.; Terwilliger, D.P.; Buckley, K.M.; Brockton, V.; Nair, S.V.; Berney, K.; et al. The immune gene repertoire encoded in the purple sea urchin genome. Dev. Biol. 2006, 300, 349–365. [Google Scholar] [CrossRef] [Scilit]
- Ren, Y.; Pan, H.; Pan, B.; Bu, W. Identification and functional characterization of three TLR signaling pathway genes in Cyclina sinensis. Fish Shellfish Immunol. 2016, 50, 150–159. [Google Scholar] [CrossRef] [Scilit]
- Wang, P.H.; Liang, J.P.; Gu, Z.H.; Wan, D.H.; Weng, S.P.; Yu, X.Q.; He, J.G. Molecular cloning, characterization and expression analysis of two novel Tolls (LvToll2 and LvToll3) and three putative Spätzle-like Toll ligands (LvSpz1-3) from Litopenaeus vannamei. Dev. Comp. Immunol. 2012, 36, 359–371. [Google Scholar] [CrossRef] [Scilit]
- Wang, W.; Zhang, T.; Wang, L.; Xu, J.; Li, M.; Zhang, A.; Qiu, L.; Song, L. A new non-phagocytic TLR6 with broad recognition ligands from Pacific oyster Crassostrea gigas. Dev. Comp. Immunol. 2016, 65, 182–190. [Google Scholar] [CrossRef] [Scilit]
- Ren, Q.; Zhong, X.; Yin, S.W.; Hao, F.Y.; Hui, K.M.; Zhang, Z.; Zhang, C.Y.; Yu, X.Q.; Wang, W. The first Toll receptor from the triangle-shell pearl mussel Hyriopsis cumingii. Fish Shellfish Immunol. 2013, 34, 1287–1293. [Google Scholar] [CrossRef] [Scilit]
- Lu, Y.; Zheng, H.; Zhang, H.; Yang, J.; Wang, Q. Cloning and differential expression of a novel toll-like receptor gene in noble scallop Chlamys nobilis with different total carotenoid content. Fish Shellfish Immunol. 2016, 56, 229–238. [Google Scholar] [CrossRef] [Scilit]
- Wang, M.; Yang, J.; Zhou, Z.; Ziu, L.; Wang, L.; Zhang, H.; Gao, Y.; Wang, X.; Zhang, L.; Zhao, J.; et al. A primitive Toll-like receptor signaling pathway in mollusk Zhikong scallop Chlamys farreri. Dev. Comp. Immunol. 2011, 35, 511–520. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Contreras-Garduño, J.; Lanz-Mendoza, H.; Franco, B.; Nava, A.; Pedraza-Reyes, M.; Canales-Lazcano, J. Insect immune priming: Ecology and experimental evidences. Ecol. Entomol. 2016, 41, 351–366. [Google Scholar] [CrossRef] [Scilit]
- Ferro, K.; Peuß, R.; Yang, W.; Rosenstiel, P.; Schulenburg, H.; Kurtz, J. Experimental evolution of immunological specificity. Proc. Natl. Acad. Sci. USA 2019, 116, 20598–20604. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kelly, B.; O’Neill, L.A.J. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015, 25, 771–784. [Google Scholar] [CrossRef] [Scilit]
- Kurtz, J. Specific memory within innate immune systems. Trends Immunol. 2005, 26, 186–192. [Google Scholar] [CrossRef] [Scilit]
- Melillo, D.; Marino, R.; Italiani, P.; Boraschi, D. Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal. Front. Immunol. 2018, 9, 1915. [Google Scholar] [CrossRef] [Scilit]
- Milutinović, B.; Kurtz, J. Immune memory in invertebrates. Semin. Immunol. 2016, 28, 328–342. [Google Scholar] [CrossRef] [Scilit]
- Yang, W.; Tran, N.T.; Zhu, C.H.; Yao, D.F.; Aweya, J.J.; Gong, Y.; Ma, H.Y.; Zhang, Y.L.; Li, G.L.; Li, S.K. Immune priming in shellfish: A review and an updating mechanistic insight focused on cellular and humoral responses. Aquaculture 2021, 530, 735831. [Google Scholar] [CrossRef] [Scilit]
- Lafont, M.; Vergnes, A.; Vidal-Dupiol, J.; de Lorgeril, J.; Gueguen, Y.; Haffner, P.; Petton, B.; Chaparro, C.; Barrachina, C.; Destoumieux-Garzon, D.; et al. A Sustained Immune Response Supports Long-Term Antiviral Immune Priming in the Pacific Oyster, Crassostrea gigas. MBio 2020, 11, 1–17. [Google Scholar] [CrossRef] [Scilit]
- Rowley, A.F.; Powell, A. Invertebrate Immune Systems–Specific, Quasi-Specific, or Nonspecific? J. Immunol. 2007, 179, 7209–7214. [Google Scholar] [CrossRef] [Scilit]
- Little, T.J.; O’Connor, B.; Colegrave, N.; Watt, K.; Read, A.F. Maternal transfer of strain-specific immunity in an invertebrate. Curr. Biol. 2003, 13, 489–492. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sadd, B.M.; Kleinlogel, Y.; Schmid-Hempel, R.; Schmid-Hempel, P. Trans-generational immune priming in a social insect. Biol. Lett. 2005, 1, 386–388. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Esteves, E.; Fogaca, A.C.; Maldonado, R.; Silva, F.D.; Manso, P.P.A.; Pelajo-Machado, M.; Valle, D.; Daffre, S. Antimicrobial activity in the tick Rhipicephalus (Boophilus) microplus eggs: Cellular localization and temporal expression of microplusin during oogenesis and embryogenesis. Dev. Comp. Immunol. 2009, 33, 913–919. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Huang, C.C.; Song, Y.L. Maternal transmission of immunity to white spot syndrome associated virus (WSSV) in shrimp (Penaeus monodon). Dev. Comp. Immunol. 1999, 23, 545–552. [Google Scholar] [CrossRef] [Scilit]
- Yue, F.; Zhou, Z.; Wang, L.; Ma, Z.; Wang, J.; Wang, M.; Zhang, H.; Song, L. Maternal transfer of immunity in scallop Chlamys farreri and its trans-generational immune protection to offspring against bacterial challenge. Dev. Comp. Immunol. 2013, 41, 569–577. [Google Scholar] [CrossRef] [Scilit]
- Wang, H.; Yang, B.; Li, Q.; Liu, S. Low-dose of formalin-inactivated Vibrio alginolyticus protects Crassostrea gigas from secondary infection and confers broad-spectrum Vibrio resistance on offspring. Dev. Comp. Immunol. 2024, 152, 105122. [Google Scholar] [CrossRef] [Scilit]
- Song, X.; Wang, W.; Dong, M.; Liu, C.; Yang, C.; Wang, L.; Song, L. Evidence for trans-generational immune priming against Vibrio splendidus in the oyster Crassostrea gigas. Front. Immunol. 2025, 16, 536562. [Google Scholar] [CrossRef] [Scilit]
- Green, T.J.; Helbig, K.; Speck, P.; Raftos, D.A. Primed for success: Oyster parents treated with poly(I:C) produce offspring with enhanced protection against Ostreid herpesvirus type I infection. Mol. Immunol. 2016, 78, 113–120. [Google Scholar] [CrossRef] [Scilit]
- Lafont, M.; Goncalves, P.; Guo, X.; Montagnani, C.; Raftos, D.; Green, T. Transgenerational plasticity and antiviral immunity in the Pacific oyster (Crassostrea gigas) against Ostreid herpesvirus 1 (OsHV-1). Dev. Comp. Immunol. 2019, 91, 17–25. [Google Scholar] [CrossRef] [Scilit]
- Dai, F.; Guo, M.; Shao, Y.; Li, C. Vibrio splendidus flagellin C binds tropomodulin to induce p38 MAPK-mediated p53-dependent coelomocyte apoptosis in Echinodermata. J. Biol. Chem. 2022, 298, 102091. [Google Scholar] [CrossRef] [Scilit]
- Wang, X.W.; Gao, J.; Xu, Y.H.; Xu, J.D.; Fan, Z.X.; Zhao, X.F.; Wang, J.X. Novel pattern recognition receptor protects shrimp by preventing bacterial colonization and promoting phagocytosis. J. Immunol. 2017, 198, 3045–3057. [Google Scholar] [CrossRef] [Scilit]
- Zhao, B.R.; Wang, X.X.; Wang, X.W. Shoc2 recognizes bacterial flagellin and mediates antibacterial Erk/Stat signaling in an invertebrate. PLoS Pathog. 2022, 18, e1010253. [Google Scholar] [CrossRef] [Scilit]
- Niu, D.; Xiong, Y.; Peng, M.; Meng, X.; Lan, T.; Li, J. Hemolytic reactions in the hemolymph of bivalve Sinonovacula constricta show complement-like activity. Fish Shellfish Immunol. 2018, 79, 11–17. [Google Scholar] [CrossRef] [Scilit]
- Wang, W.; Wei, Z.; Wang, X. Flagellin enhances shrimp antiviral immunity through the Shoc2/Erk/Stat/Ficolin pathway. Aquaculture 2025, 603, 742415. [Google Scholar] [CrossRef] [Scilit]
- Dostert, C.; Jouanguy, E.; Irving, P.; Troxler, L.; Galiana-Arnoux, D.; Hetru, C.; Hoffmann, J.A.; Imler, J.L. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of Drosophila. Nat. Immunol. 2005, 6, 946–953. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gao, J.; Zhao, B.R.; Zhang, H.; You, Y.L.; Li, F.; Wang, X.W. Interferon functional analog activates antiviral Jak/Stat signaling through integrin in an arthropod. Cell Rep. 2021, 36, 109761. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- West, C.; Silverman, N. p38b and JAK-STAT signaling protect against Invertebrate iridescent virus 6 infection in Drosophila. PLoS Pathog. 2018, 14, e1007020. [Google Scholar] [CrossRef] [Scilit]
- Keirstead, N.D.; Lee, C.; Yoo, D.; Brooks, A.S.; Hayes, M.A. Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro. Antivir. Res. 2008, 77, 28–38. [Google Scholar] [CrossRef] [Scilit]
- Liu, J.; Ali, M.A.M.; Shi, Y.; Zhao, Y.; Luo, F.; Yu, J.; Xiang, T.; Tang, J.; Li, D.; Hu, Q.; et al. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell. Mol. Immunol. 2009, 6, 235–244. [Google Scholar] [CrossRef] [Scilit]
- Cho, H.; Park, N.H.; Jang, Y.; Gwon, Y.D.; Cho, Y.; Heo, Y.K.; Park, K.H.; Lee, H.J.; Choi, T.J.; Kim, Y.B. Fusion of flagellin 2 with bivalent white spot syndrome virus vaccine increases survival in freshwater shrimp. J. Invertebr. Pathol. 2017, 144, 97–105. [Google Scholar] [CrossRef] [Scilit]
- Boonyakida, J.; Xu, J.; Satoh, J.; Nakanishi, T.; Mekata, T.; Kato, T.; Park, E.Y. Antigenic properties of VP15 from white spot syndrome virus in kuruma shrimp Marsupenaeus japonicus. Fish Shellfish Immunol. 2020, 101, 152–158. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Boonyakida, J.; Xu, J.; Satoh, J.; Nakanishi, T.; Mekata, T.; Kato, T.; Park, E.Y. Identification of antigenic domains and peptides from VP15 of white spot syndrome virus and their antiviral effects in Marsupenaeus japonicus. Sci. Rep. 2021, 11, 12766. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Boonyakida, J.; Nakanishi, T.; Satoh, J.; Shimahara, Y.; Mekata, T.; Park, E.Y. Immunostimulation of shrimp through oral administration of silkworm pupae expressing VP15 against WSSV. Fish Shellfish Immunol. 2022, 128, 157–167. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Namikoshi, A.; Wu, J.L.; Yamashita, T.; Nishizawa, T.; Nishioka, T.; Arimoto, M.; Muroga, K. Vaccination trials with Penaeus japonicus to induce resistance to white spot syndrome virus. Aquaculture 2004, 229, 25–35. [Google Scholar] [CrossRef] [Scilit]
- Satoh, J.; Nishizawa, T.; Yoshimizu, M. Protection against white spot syndrome virus (WSSV) infection in kuruma shrimp orally vaccinated with WSSV rVP26 and rVP28. Dis. Aquat. Org. 2008, 82, 89–96. [Google Scholar] [CrossRef] [Scilit]
- Syed Musthaq, S.; Madhan, S.; Sahul Hameed, A.S.; Kwang, J. Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon. Virology 2009, 391, 315–324. [Google Scholar] [CrossRef] [Scilit]
- Witteveldt, J.; Vlak, J.M.; Van Hulten, M.C.W. Protection of Penaeus monodon against white spot syndrome virus using a WSSV subunit vaccine. Fish Shellfish Immunol. 2004, 16, 571–579. [Google Scholar] [CrossRef] [Scilit]
- Chang, Y.S.; Liu, W.J.; Lee, C.C.; Chou, T.L.; Lee, Y.T.; Wu, T.S.; Huang, J.Y.; Huang, W.T.; Lee, T.L.; Kou, G.H.; et al. A 3D model of the membrane protein complex formed by the white spot syndrome virus structural proteins. PLoS ONE 2010, 5, e10718. [Google Scholar] [CrossRef] [Scilit]
- Verbruggen, B.; Bickley, L.K.; van Aerle, R.; Bateman, K.S.; Stentiford, G.D.; Santos, E.M.; Tyler, C.R. Molecular mechanisms of white spot syndrome virus infection and perspectives on treatments. Viruses 2016, 8, 23. [Google Scholar] [CrossRef] [Scilit]
- Yi, G.; Wang, Z.; Qi, Y.; Yao, L.; Qian, J.; Hu, L. Vp28 of shrimp white spot syndrome virus is involved in the attachment and penetration into shrimp cells. BMB Rep. 2004, 37, 726–734. [Google Scholar] [CrossRef] [Scilit]
- Jha, R.K.; Xu, Z.R.; Shen, J.; Bai, S.J.; Sun, J.Y.; Li, W.F. The efficacy of recombinant vaccines against white spot syndrome virus in Procambarus clarkii. Immunol. Lett. 2006, 105, 68–76. [Google Scholar] [CrossRef] [Scilit]
- Witteveldt, J.; Cifuentes, C.C.; Vlak, J.M.; Van Hulten, M.C.W. Protection of Penaeus monodon against White Spot Syndrome Virus by Oral Vaccination. J. Virol. 2004, 78, 2057–2061. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jha, R.K.; Xu, Z.R.; Pandey, A. Protection of Procambarus clarkii against white spot syndrome virus using recombinant subunit injection vaccine expressed in Pichia pastoris. Fish. Sci. 2006, 72, 1011–1019. [Google Scholar] [CrossRef] [Scilit]
- Syed Musthaq, S.; Kwang, J. Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against white spot syndrome virus in Penaeus monodon. PLoS ONE 2011, 6, e26428. [Google Scholar] [CrossRef] [Scilit]
- Kono, T.; Fall, J.; Korenaga, H.; Sudhakaran, R.; Biswas, G.; Mekata, T.; Itami, T.; Sakai, M. Recombinant VP28 produced by cell-free technique confers protection in Kuruma shrimp (Marsupenaeus japonicus) against white spot syndrome virus. Turk. J. Fish. Aquat. Sci. 2014, 14, 547–555. [Google Scholar] [CrossRef]
- Ha, Y.M.; Gong, S.J.; Nguyen, T.H.; Ra, C.H.; Kim, K.H.; Nam, Y.K.; Kim, S.K. Vaccination of shrimp (Penaeus chinensis) against White Spot Syndrome Virus (WSSV). J. Microbiol. Biotechnol. 2008, 18, 964–967. [Google Scholar] [PubMed]
- Du, H.; Xu, Z.; Wu, X.; Li, W.; Dai, W. Increased resistance to white spot syndrome virus in Procambarus clarkii by injection of envelope protein VP28 expressed using recombinant baculovirus. Aquaculture 2006, 260, 39–43. [Google Scholar] [CrossRef] [Scilit]
- Yang, J.; Chi, X.P.; Li, M.; He, W.H.; Jia, R.; He, P.M. Oral administration of Synechococcus sp. PCC7942 trans-vp19 and trans-vp (19 + 28) genes improve the immune and antioxidant capacity in Procambarus clarkii under white spot syndrome virus stress. Fish Shellfish Immunol. 2023, 132, 108471. [Google Scholar] [CrossRef] [Scilit]
- Jha, R.K.; Xu, Z.R.; Bai, S.J.; Sun, J.Y.; Li, W.F.; Shen, J. Protection of Procambarus clarkii against white spot syndrome virus using recombinant oral vaccine expressed in Pichia pastoris. Fish Shellfish Immunol. 2007, 22, 295–307. [Google Scholar] [CrossRef] [Scilit]
- Xu, Z.; Du, H.; Xu, Y.; Sun, J.; Shen, J. Crayfish Procambarus clarkii protected against white spot syndrome virus by oral administration of viral proteins expressed in silkworms. Aquaculture 2006, 253, 179–183. [Google Scholar] [CrossRef] [Scilit]
- Wei, K.Q.; Xu, Z.R. Effects of oral recombinant VP28 expressed in silkworm (Bombyx mori) pupa on immune response and disease resistance of Procambarus clarkii. World J. Microbiol. Biotechnol. 2009, 25, 1321–1328. [Google Scholar] [CrossRef] [Scilit]
- Zhu, C.; Shi, D.; Liao, S.; He, P.; Jia, R. Effects of Synechococcus sp. PCC 7942 harboring vp19, vp28, and vp (19 + 28) on the survival and immune response of Litopenaeus vannamei infected WSSV. Fish Shellfish Immunol. 2020, 99, 1–8. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ran, C.M.; Kim, Y.J.; Jang, J.S.; Kim, S.K. Transcriptional analysis for oral vaccination of recombinant viral proteins against white spot syndrome virus (WSSV) in Litopenaeus vannamei. J. Microbiol. Biotechnol. 2011, 21, 170–175. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Caipang, C.M.A.; Verjan, N.; Ooi, E.L.; Kondo, H.; Hirono, I.; Aoki, T.; Kiyono, H.; Yuki, Y. Enhanced survival of shrimp, Penaeus (Marsupenaeus) japonicus from white spot syndrome disease after oral administration of recombinant VP28 expressed in Brevibacillus brevis. Fish Shellfish Immunol. 2008, 25, 315–320. [Google Scholar] [CrossRef] [Scilit]
- Mavichak, R.; Kondo, H.; Hirono, I.; Aoki, T.; Kiyono, H.; Yuki, Y. Protection of Pacific White Shrimp, Litopenaeus vannamei against White Spot Virus Following Administration of N-terminus Truncated Recombinant VP28 Protein Expressed in Gram-positive Bacteria, Brevibacillus choshinensis. Aquac. Sci. 2009, 57, 83902009. [Google Scholar]
- Ding, N.; Yang, J.; Zhang, H.; Qi, X.; Liu, F.; Shen, Y.; Jia, R. Effects of high vp28 expression in Synechocystis sp. PCC6803 constructed by homologous recombination on immunity and antioxidant capacity of white spot syndrome virus infected Litopenaeus vannamei. Aquac. Int. 2025, 33, 76. [Google Scholar] [CrossRef] [Scilit]
- Zhai, Y.F.; Xu, R.H.; Yang, Z.F.; Chi, X.P.; Wei, S.Y.; He, P.M.; Jia, R. The role of trans-vp28 gene Synechocystis sp. PCC6803 in the defense against white spot syndrome virus (WSSV). Aquaculture 2021, 539, 736613. [Google Scholar] [CrossRef] [Scilit]
- Le Linh, H.; Thu, N.P.A.; Dung, T.T.X.; Van Hau, N.; Nghia, N.H.; Thao, D.T.P. Yeast cell surface displaying VP28 antigen and its potential application for shrimp farming. Appl. Microbiol. Biotechnol. 2021, 105, 6345–6354. [Google Scholar] [CrossRef] [Scilit]
- Fu, L.L.; Shuai, J.B.; Xu, Z.R.; Li, J.R.; Li, W.F. Immune responses of Fenneropenaeus chinensis against white spot syndrome virus after oral delivery of VP28 using Bacillus subtilis as vehicles. Fish Shellfish Immunol. 2010, 28, 49–55. [Google Scholar] [CrossRef] [Scilit]
- Tong, Y.; Yang, J.; Wang, L.; Chi, X.; Zhu, C.; Yin, R.; Zhang, L.; Li, Y.; Zhao, C.; Jia, R. Effects of dietary supplementation of Anabaena sp. PCC7120 expressing VP28 protein on survival and histopathology after WSSV infection in Macrobrachium nipponense. Fish Shellfish Immunol. 2023, 139, 108865. [Google Scholar] [CrossRef] [Scilit]
- Jia, X.H.; Zhang, C.L.; Shi, D.J.; Zhuang, M.M.; Wang, X.; Jia, R.; Zhang, Z.Y.; Huang, J.; Sun, Y.H.; Qian, W.Y.; et al. Oral administration of Anabaena-expressed VP28 for both drug and food against white spot syndrome virus in shrimp. J. Appl. Phycol. 2016, 28, 1001–1009. [Google Scholar] [CrossRef] [Scilit]
- Kiataramgul, A.; Maneenin, S.; Purton, S.; Areechon, N.; Hirono, I.; Brocklehurst, T.W.; Unajak, S. An oral delivery system for controlling white spot syndrome virus infection in shrimp using transgenic microalgae. Aquaculture 2020, 521, 735022. [Google Scholar] [CrossRef] [Scilit]
- Lanh, P.T.; Nguyen, H.M.; Duong, B.T.T.; Hoa, N.T.; Thom, L.T.; Tam, L.T.; Thu, H.T.; Nha, V.V.; Hong, D.D.; Mouradov, A.; et al. Generation of microalga Chlamydomonas reinhardtii expressing VP28 protein as oral vaccine candidate for shrimps against White Spot Syndrome Virus (WSSV) infection. Aquaculture 2021, 540, 736737. [Google Scholar] [CrossRef] [Scilit]
- Fu, L.L.; Li, W.F.; Du, H.H.; Dai, W.; Xu, Z.R. Oral vaccination with envelope protein VP28 against white spot syn-drome virus in Procambarus clarkii using Bacillus subtilis as delivery vehicles. Lett. Appl. Microbiol. 2008, 46, 581–586. [Google Scholar] [CrossRef] [Scilit]
- Ning, D.; Leng, X.; Li, Q.; Xu, W. Surface-displayed VP28 on Bacillus subtilis spores induce protection against white spot syndrome virus in crayfish by oral administration. J. Appl. Microbiol. 2011, 111, 1327–1336. [Google Scholar] [CrossRef] [Scilit]
- Nguyen, A.T.V.; Pham, C.K.; Pham, H.T.T.; Pham, H.L.; Nguyen, A.H.; Dang, L.T.; Huynh, H.A.; Cutting, S.M.; Phan, T.N. Bacillus subtilis spores expressing the VP28 antigen: A potential oral treatment to protect Litopenaeus vannamei against white spot syndrome. FEMS Microbiol. Lett. 2014, 358, 202–208. [Google Scholar] [CrossRef] [Scilit]
- Valdez, A.; Yepiz-Plascencia, G.; Ricca, E.; Olmos, J. First Litopenaeus vannamei WSSV 100% oral vaccination protection using CotC::Vp26 fusion protein displayed on Bacillus subtilis spores surface. J. Appl. Microbiol. 2014, 117, 347–357. [Google Scholar] [CrossRef] [Scilit]
- Yang, J.Y.; Chang, C.I.; Liu, K.F.; Hseu, J.R.; Chen, L.H.; Tsai, J.M. Viral resistance and immune responses of the shrimp Litopenaeus vannamei vaccinated by two WSSV structural proteins. Immunol. Lett. 2012, 148, 41–48. [Google Scholar] [CrossRef] [Scilit]
- Wang, Q.; Xu, Y.; Xiao, C.; Zhu, F. The effect of white spot syndrome virus (WSSV) envelope protein VP28 on innate immunity and resistance to white spot syndrome virus in Cherax quadricarinatus. Fish Shellfish Immunol. 2023, 137, 108795. [Google Scholar] [CrossRef] [Scilit]
- Lei, H.; Li, S.; Lu, X.; Ren, Y. Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp. Virus Res. 2021, 302, 198467. [Google Scholar] [CrossRef] [Scilit]
- Bangrak, P.; Graidist, P.; Chotigeat, W.; Phongdara, A. Molecular cloning and expression of a mammalian homologue of a translationally controlled tumor protein (TCTP) gene from Penaeus monodon shrimp. J. Biotechnol. 2004, 108, 219–226. [Google Scholar] [CrossRef] [Scilit]
- Tonganunt, M.; Nupan, B.; Saengsakda, M.; Suklour, S.; Wanna, W.; Senapin, S.; Chotigeat, W.; Phongdara, A. The role of Pm–fortilin in protecting shrimp from white spot syndrome virus (WSSV) infection. Fish Shellfish Immunol. 2008, 25, 633–637. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sinthujaroen, P.; Tonganunt-Srithaworn, M.; Eurwilaichitr, L.; Phongdara, A. Protection of Litopenaeus vannamei against the white spot syndrome virus using recombinant Pm-fortilin expressed in Pichia pastoris. Aquaculture 2015, 435, 450–457. [Google Scholar] [CrossRef] [Scilit]
- Pathan, M.; Gireesh-Babu, P.; Pavan-Kumar, A.; Jeena, K.; Sharma, R.; Makesh, M.; Prasad, K.P.; Krishna, G. In vivo therapeutic efficacy of recombinant Penaeus monodon antiviral protein (rPmAV) administered in three different forms to WSSV infected Penaeus monodon. Aquaculture 2013, 376–379, 64–67. [Google Scholar] [CrossRef] [Scilit]
- Sritunyalucksana, K.; Wannapapho, W.; Lo, C.F.; Flegel, T.W. PmRab7 Is a VP28-Binding Protein Involved in White Spot Syndrome Virus Infection in Shrimp. J. Virol. 2006, 80, 10734–10742. [Google Scholar] [CrossRef] [Scilit]
- Thagun, C.; Srisala, J.; Sritunyalucksana, K.; Narangajavana, J.; Sojikul, P. Arabidopsis-derived shrimp viral-binding protein, PmRab7 can protect white spot syndrome virus infection in shrimp. J. Biotechnol. 2012, 161, 60–67. [Google Scholar] [CrossRef] [Scilit]
- Ananphongmanee, V.; Lertpreedakorn, N.; Taengchaiyaphum, S.; Charoenrat, T.; Sritunyalucksana, K.; Boonchird, C. Shrimp protected from a virus by feed containing yeast with a surface-displayed viral binding protein. J. Biotechnol. 2021, 342, 45–53. [Google Scholar] [CrossRef] [Scilit]
- Bucci, C.; Thomsen, P.; Nicoziani, P.; McCarthy, J.; Van Deurs, B. Rab7: A key to lysosome biogenesis. Mol. Biol. Cell 2000, 11, 467–480. [Google Scholar] [CrossRef] [Scilit]
- Méresse, S.; Gorvel, J.P.; Chavrier, P. The rab7 GTPase resides on a vesicular compartment connected to lysosomes. J. Cell Sci. 1995, 108, 3349–3358. [Google Scholar] [CrossRef] [Scilit]
- Pan, D.; He, N.; Yang, Z.; Liu, H.; Xu, X. Differential gene expression profile in hepatopancreas of WSSV-resistant shrimp (Penaeus japonicus) by suppression subtractive hybridization. Dev. Comp. Immunol. 2005, 29, 103–112. [Google Scholar] [CrossRef] [Scilit]
- Hur, S. Double-stranded RNA sensors and modulators in innate immunity. Annu. Rev. Immunol. 2019, 37, 349–375. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alexopoulou, L.; Holt, A.; Medzhitov, R.; Flavell, R. Recognition of double-stranded RNA and activation of NF-kappaB by Toll. Nature 2001, 413, 732–738. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Duan, T.; Du, Y.; Xing, C.; Wang, H.Y.; Wang, R.F. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Front. Immunol. 2022, 13, 812774. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wicherska-pawłowska, K.; Wróbel, T.; Rybka, J. Toll-like receptors (Tlrs), nod-like receptors (nlrs) and rig-i-like receptors (rlrs) in innate immunity. tlrs, nlrs and rlrs ligands as immunotherapeutic agents for hematopoietic diseases. Int. J. Mol. Sci. 2021, 22, 13397. [Google Scholar] [CrossRef] [Scilit]
- Flenniken, M.L.; Andino, R. Non-Specific dsRNA-Mediated Antiviral Response in the Honey Bee. PLoS ONE 2013, 8, e77263. [Google Scholar] [CrossRef] [Scilit]
- Green, T.J.; Montagnani, C. Poly I: C induces a protective antiviral immune response in the Pacific oyster (Crassostrea gigas) against subsequent challenge with Ostreid herpesvirus (OsHV-1 μvar). Fish Shellfish Immunol. 2013, 35, 382–388. [Google Scholar] [CrossRef] [Scilit]
- Robalino, J.; Browdy, C.L.; Prior, S.; Metz, A.; Parnell, P.; Gross, P.; Warr, G. Induction of Antiviral Immunity by Double-Stranded RNA in a Marine Invertebrate. J. Virol. 2004, 78, 10442–10448. [Google Scholar] [CrossRef] [Scilit]
- Yodmuang, S.; Tirasophon, W.; Roshorm, Y.; Chinnirunvong, W.; Panyim, S. YHV-protease dsRNA inhibits YHV replication in Penaeus monodon and prevents mortality. Biochem. Biophys. Res. Commun. 2006, 341, 351–356. [Google Scholar] [CrossRef] [Scilit]
- Labreuche, Y.; Veloso, A.; de la Vega, E.; Gross, P.S.; Chapman, R.W.; Browdy, C.L.; Warr, G.W. Non-specific activation of antiviral immunity and induction of RNA interference may engage the same pathway in the Pacific white leg shrimp Litopenaeus vannamei. Dev. Comp. Immunol. 2010, 34, 1209–1218. [Google Scholar] [CrossRef] [Scilit]
- Maralit, B.A.; Komatsu, M.; Hipolito, S.G.; Hirono, I.; Kondo, H. Microarray Analysis of Immunity Against WSSV in Response to Injection of Non-specific Long dsRNA in Kuruma Shrimp, Marsupenaeus japonicus. Mar. Biotechnol. 2015, 17, 493–501. [Google Scholar] [CrossRef] [Scilit]
- Kono, T.; Biswas, G.; Fall, J.; Mekata, T.; Hikima, J.; Itami, T.; Sakai, M. Adjuvant effects of poly I: C and imiquimod on the immunization of kuruma shrimp (Marsupenaeus japonicus) with a recombinant protein, VP28 against white spot syndrome virus. Aquaculture 2015, 446, 236–241. [Google Scholar] [CrossRef] [Scilit]
- Lafont, M.; Petton, B.; Vergnes, A.; Pauletto, M.; Segarra, A.; Gourbal, B.; Montagnani, C. Long-lasting antiviral innate immune priming in the Lophotrochozoan Pacific oyster, Crassostrea gigas. Sci. Rep. 2017, 7, 13143. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Robinson, A.N.; Green, T.J. Fitness costs associated with maternal immune priming in the oyster. Fish Shellfish Immunol. 2020, 103, 32–36. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kantzow, M.; De Hick, P.M.; Whittington, R.J. Immune Priming of Pacific Oysters (Crassostrea gigas) to Induce Resistance to Ostreid herpesvirus 1: Comparison of Infectious and Inactivated OsHV-1 with Poly I:C. Viruses 2023, 15, 1943. [Google Scholar] [CrossRef] [Scilit]
- Agius, J.R.; Ackerly, D.; Watson, A.C.; Smith, M.L.; Beddoe, T.; Helbig, K.J. Reducing the impact of HaHV-1 in Australian abalone: The role of age and immune priming. J. Invertebr. Pathol. 2026, 216, 108554. [Google Scholar] [CrossRef] [Scilit]
- Wang, B.; Li, F.; Dong, B.; Zhang, X.; Zhang, C.; Xiang, J. Discovery of the genes in response to white spot syndrome virus (WSSV) infection in Fenneropenaeus chinensis through cDNA microarray. Mar. Biotechnol. 2006, 8, 491–500. [Google Scholar] [CrossRef] [Scilit]
- Danwattananusorn, T.; Fagutao, F.F.; Shitara, A.; Kondo, H.; Aoki, T.; Nozaki, R.; Hirono, I. Molecular characterization and expression analysis of heat shock proteins 40, 70 and 90 from kuruma shrimp Marsupenaeus japonicus. Fish. Sci. 2011, 77, 929–937. [Google Scholar] [CrossRef] [Scilit]
- Xu, Y.H.; Bi, W.J.; Wang, X.W.; Zhao, Y.R.; Zhao, X.F.; Wang, J.X. Two novel C-type lectins with a low-density lipoprotein receptor class A domain have antiviral function in the shrimp Marsupenaeus japonicus. Dev. Comp. Immunol. 2014, 42, 323–332. [Google Scholar] [CrossRef] [Scilit]
- Prapavorarat, A.; Vatanavicharn, T.; Söderhäll, K.; Tassanakajon, A. A novel viral responsive protein is involved in hemocyte homeostasis in the black tiger shrimp, Penaeus monodon. J. Biol. Chem. 2010, 285, 21467–21477. [Google Scholar] [CrossRef] [Scilit]
- Vatanavicharn, T.; Prapavorarat, A.; Jaree, P.; Somboonwiwat, K.; Tassanakajon, A. PmVRP15, a novel viral responsive protein from the black tiger shrimp, Penaeus monodon, promoted white spot syndrome virus replication. PLoS ONE 2014, 9, e91930. [Google Scholar] [CrossRef] [Scilit]
- Schön, M.P.; Schön, M. Imiquimod: Mode of action. Br. J. Dermatol. 2007, 157, 8–13. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kono, T.; Fall, J.; Korenaga, H.; Takayama, H.; Iizasa, T.; Mekata, T.; Itami, T.; Sakai, M. Immunomodulation by DNA vaccination against white spot syndrome virus (WSSV). Asian Fish. Sci. 2010, 23, 435–446. [Google Scholar] [CrossRef] [Scilit]
- Gupta, D.; Khandelwal, R.L. Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor-α in HepG2 cells. Biochim. Biophys. Acta (BBA)-Gen. Subj. 2004, 1671, 51–58. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Garner, J.N.; Joshi, B.; Jagus, R. Characterization of rainbow trout and zebrafish eukaryotic initiation factor 2α and its response to endoplasmic reticulum stress and IPNV infection. Dev. Comp. Immunol. 2003, 27, 217–231. [Google Scholar] [CrossRef] [Scilit]
- Renault, T.; Faury, N.; Barbosa-Solomieu, V.; Moreau, K. Suppression substractive hybridisation (SSH) and real time PCR reveal differential gene expression in the Pacific cupped oyster, Crassostrea gigas, challenged with Ostreid herpesvirus 1. Dev. Comp. Immunol. 2011, 35, 725–735. [Google Scholar] [CrossRef] [Scilit]
- Zhang, Y.; Song, L.; Zhao, J.; Wang, L.; Kong, P.; Liu, L.; Wang, M.; Qiu, L. Protective immunity induced by CpG ODNs against white spot syndrome virus (WSSV) via intermediation of virus replication indirectly in Litopenaeus vannamei. Dev. Comp. Immunol. 2010, 34, 418–424. [Google Scholar] [CrossRef] [Scilit]
- Yi, Q.; Liu, R.; Sun, R.; Wang, L.; Zhou, Z.; Wang, M.; Liu, Y.; Sun, J.; Madzak, C.; Song, L. The protection of CpG ODNs and Yarrowia lipolytica harboring VP28 for shrimp Litopenaeus vannamei against White spot syndrome virus infection. Invertebr. Surviv. J. 2014, 11, 119–131. [Google Scholar]
- Sun, R.; Yue, F.; Qiu, L.; Zhang, Y.; Wang, L.; Zhou, Z.; Zhang, H.; Yi, Q.; Song, L. The CpG ODNs enriched diets enhance the immuno-protection efficiency and growth rate of Chinese mitten crab, Eriocheir sinensis. Fish Shellfish Immunol. 2013, 35, 154–160. [Google Scholar] [CrossRef] [Scilit]
- Rout, N.; Kumar, S.; Jaganmohan, S.; Murugan, V. DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp. Vaccine 2007, 25, 2778–2786. [Google Scholar] [CrossRef] [Scilit]
- Kumar, S.R.; Ahamed, V.I.; Sarathi, M.; Basha, A.N.; Hameed, A.S. Immunological responses of Penaeus monodon to DNA vaccine and its efficacy to protect shrimp against white spot syndrome virus (WSSV). Fish Shellfish Immunol. 2008, 24, 467–478. [Google Scholar] [CrossRef] [Scilit]
- Rajeshkumar, S.; Venkatesan, C.; Sarathi, M.; Sarathbabu, V.; Thomas, J.; Anver Basha, K.; Sahul Hameed, A.S. Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV). Fish Shellfish Immunol. 2009, 26, 429–437. [Google Scholar] [CrossRef] [Scilit]
- Ning, J.F.; Zhu, W.; Xu, J.P.; Zheng, C.Y.; Meng, X.L. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Vaccine 2009, 27, 1127–1135. [Google Scholar] [CrossRef] [Scilit]
- Li, X.; Liu, Q.H.; Hou, L.; Huang, J. Effect of VP28 DNA vaccine on white spot syndrome virus in Litopenaeus vannamei. Aquac. Int. 2010, 18, 1035–1044. [Google Scholar] [CrossRef] [Scilit]
- Kono, T.; Sonoda, K.; Kitao, Y.; Mekata, T.; Itami, T.; Sakai, M. The expression analysis of innate immune-related genes in kuruma shrimp Penaeus Japonicus after DNA vaccination against penaeid rod-shaped DNA virus. Fish Pathol. 2009, 44, 94–97. [Google Scholar] [CrossRef] [Scilit]
- Ravi, M.; Sudhakar, T.; Hari Haran, S.; Sudhakaran, R.; Stalin Dhas, T. Nanoparticles based DNA vaccine in marine water crabs (Scylla serrata) for protection against white spot syndrome virus (WSSV). Biocatal. Agric. Biotechnol. 2020, 28, 101764. [Google Scholar] [CrossRef] [Scilit]
- Mu, Y.; Lan, J.F.; Zhang, X.W.; Wang, X.W.; Zhao, X.F.; Wang, J.X. A vector that expresses VP28 of WSSV can protect red swamp crayfish from white spot disease. Dev. Comp. Immunol. 2012, 36, 442–449. [Google Scholar] [CrossRef] [Scilit]
- Ramya, V.L.; Sharma, R.; Gireesh-Babu, P.; Patchala, S.R.; Rather, A.; Nandanpawar, P.C.; Eswaran, S. Development of chitosan conjugated DNA vaccine against nodavirus in Macrobrachium rosenbergii (De Man, 1879). J. Fish Dis. 2014, 37, 815–824. [Google Scholar] [CrossRef] [Scilit]
- Citarasu, T.; Lelin, C.; Thirumalaikumar, E.; Michael Babu, M.; Vakharia, V.N. Macrobrachium rosenbergii nodavirus (MrNV)-CP-RNA-2 DNA vaccine confers protective immunity in giant freshwater prawn Macrobrachium rosenbergii against MrNV infection. Fish Shellfish Immunol. 2019, 86, 319–326. [Google Scholar] [CrossRef] [Scilit]
- Bauer, S.; Kirschning, C.J.; Häcker, H.; Redecke, V.; Hausmann, S.; Akira, S.; Wagner, H.; Lipford, G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 2001, 98, 9237–9242. [Google Scholar] [CrossRef] [Scilit]
- Takeshita, F.; Leifer, C.A.; Gursel, I.; Ishii, K.J.; Takeshita, S.; Gursel, M.; Klinman, D.M. Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells. J. Immunol. 2001, 167, 3555–3558. [Google Scholar] [CrossRef] [Scilit]
- Chen, Y.; Xiang, L.X.; Shao, J.Z. Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals. Fish Shellfish Immunol. 2007, 23, 589–600. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chuo, C.P.; Liang, S.M.; Sung, H.H. Signal transduction of the prophenoloxidase activating system of prawn haemocytes triggered by CpG oligodeoxynucleotides. Fish Shellfish Immunol. 2005, 18, 149–162. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lu, K.Y.; Huang, Y.T.; Lee, H.H.; Sung, H.H. Cloning the prophenoloxidase cDNA and monitoring the expression of proPO mRNA in prawns (Macrobrachium rosenbergii) stimulated in vivo by CpG oligodeoxynucleotides. Fish Shellfish Immunol. 2006, 20, 274–284. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sung, H.H.; Chen, P.H.; Liu, C.L. Initiation of signal transduction of the respiratory burst of prawn haemocytes triggered by CpG oligodeoxynucleotides. Fish Shellfish Immunol. 2008, 24, 693–700. [Google Scholar] [CrossRef] [Scilit]
- Hong, X.T.; Xiang, L.X.; Shao, J.Z. The immunostimulating effect of bacterial genomic DNA on the innate immune responses of bivalve mussel, Hyriopsis cumingii Lea. Fish Shellfish Immunol. 2006, 21, 357–364. [Google Scholar] [CrossRef] [Scilit]
- Xu, J.; Zhao, D.; Sun, M.; Wang, L.; Jia, Z.; Liu, R.; Wang, L.; Song, L. A-type CpG ODN with higher binding affinity to LvToll1 could probably activate downstream IFN system-like antiviral response in shrimp Litopenaeus vannamei. Invertebr. Surviv. J. 2016, 13, 397–410. [Google Scholar]
- Tassakka, A.C.M.A.R.; Seniati Ramadhani, S.; Aslamyah, S.; Nursida, N.F. Evaluation of CpG-Oligodeoxynucleotides as Immunostimulants and Protecting Agents Against Aeromonas hydrophila in Freshwater Lobster (Cherax quadricarinatus). Bull. Eur. Assoc. Fish Pathol. 2024, 44, 13. [Google Scholar] [CrossRef] [Scilit]
- Thompson, I.J.; Oyston, P.C.F.; Williamson, D.E. Potential of the β-glucans to enhance innate resistance to biological agents. Expert Rev. Anti-Infect. Ther. 2010, 8, 339–352. [Google Scholar] [CrossRef] [Scilit]
- Chang, C.F.; Su, M.S.; Chen, H.Y.; Liao, I.C. Dietary β-1,3-glucan effectively improves immunity and survival of Penaeus monodon challenged with white spot syndrome virus. Fish Shellfish Immunol. 2003, 15, 297–310. [Google Scholar] [CrossRef] [Scilit]
- Chang, C.F.; Su, M.S.; Chen, H.Y.; Lo, C.F.; Kou, G.H.; Liao, I.C. Effect of dietary β-1,3-glucan on resistance to white syndrome virus (WSSV) in postlarval and juvenile Penaeus monodon. Dis. Aquat. Org. 1999, 36, 163–168. [Google Scholar] [CrossRef] [Scilit]
- Pacheco, R.; Ascencio, F.; Zarain, M.; Gómez, G.; Campa, Á. Enhancement of superoxide dismutase and catalase activity in juvenile brown shrimp, Farfantepenaeus californiensis (Holmes, 1900), fed β-1.3 glucan vitamin E, and β-carotene and infected with white spot syndrome virus. Lat. Am. J. Aquat. Res. 2011, 39, 534–543. [Google Scholar] [CrossRef] [Scilit]
- Ghaednia, B.; Mirbakshs, M.; Sharifpour, I.; Mehrabi, M.R.; Yeghaneh, V.; Shamsiyan, S. Dietary Administration of Yeast β 1,3 1,6 Glucan on Immunity and Survival Rate of White Indian Shrimp, Fennerpenaeus indicus Challenged with White Spot Syndrome Disease. J. Adv. Vet. Res. 2012, 2, 24–31. [Google Scholar]
- Sukumaran, V.; Lowman, D.W.; Sajeevan, T.P.; Philip, R. Marine yeast glucans confer better protection than that of baker’s yeast in Penaeus monodon against white spot syndrome virus infection. Aquac. Res. 2010, 41, 1799–1805. [Google Scholar] [CrossRef] [Scilit]
- Antony, S.P.; Singh, I.S.B.; Sudheer, N.S.; Vrinda, S.; Priyaja, P.; Philip, R. Molecular characterization of a crustin-like antimicrobial peptide in the giant tiger shrimp, Penaeus monodon, and its expression profile in response to various immunostimulants and challenge with WSSV. Immunobiology 2011, 216, 184–194. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sajeevan, T.P.; Philip, R.; Bright Singh, I.S. Dose/frequency: A critical factor in the administration of glucan as immunostimulant to Indian white shrimp Fenneropenaeus indicus. Aquaculture 2009, 287, 248–252. [Google Scholar] [CrossRef] [Scilit]
- Bai, N.; Gu, M.; Zhang, W.; Xu, W.; Mai, K. Effects of β-glucan derivatives on the immunity of white shrimp Litopenaeus vannamei and its resistance against white spot syndrome virus infection. Aquaculture 2014, 426–427, 66–73. [Google Scholar] [CrossRef] [Scilit]
- Luan, L.Q.; Vu, N.T.; Nghia, N.T.; Thao, N.H.P. Synergic degradation of yeast β-glucan with a potential of immunostimulant and growth promotor for tiger shrimp. Aquac. Rep. 2021, 21, 100858. [Google Scholar] [CrossRef] [Scilit]
- Ochoa-álvarez, N.A.; Casillas-Hernández, R.; Magallón-Barajas, F.J.; Ramirez-Orozco, J.M.; Carbajal-Millan, E. Protector effect of beta-glucans from shrimp pond-related yeasts in penaeus vannamei rearing under white spot syndrome virus presence. Lat. Am. J. Aquat. Res. 2021, 49, 18–28. [Google Scholar] [CrossRef] [Scilit]
- Wilson, W.; Lowman, D.; Antony, S.P.; Puthumana, J.; Bright Singh, I.S.; Philip, R. Immune gene expression profile of Penaeus monodon in response to marine yeast glucan application and white spot syndrome virus challenge. Fish Shellfish Immunol. 2015, 43, 346–356. [Google Scholar] [CrossRef] [Scilit]
- Licona-Jain, A.; Racotta, I.; Angulo, C.; Luna-González, A.; Escamilla-Montes, R.; Cortés-Jacinto, E.; Morelos-Castro, R.M.; Campa-Córdova, Á.I. Combined administration routes of marine yeasts enhanced immune-related genes and protection of white shrimp (Penaeus vannamei) against Vibrio parahaemolyticus. Fish Shellfish Immunol. 2022, 124, 192–200. [Google Scholar] [CrossRef] [Scilit]
- Pooljun, C.; Jariyapong, P.; Wongtawan, T.; Hirono, I.; Wuthisuthimethavee, S. Effect of feeding different types of β-glucans derived from two marine diatoms (Chaetoceros muelleri and Thalassiosira weissflogii) on growth performance and immunity of banana shrimp (Penaeus merguiensis). Fish Shellfish Immunol. 2022, 130, 512–519. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Marques, A.; Dhont, J.; Sorgeloos, P.; Bossier, P. Immunostimulatory nature of β-glucans and baker’s yeast in gnotobiotic Artemia challenge tests. Fish Shellfish Immunol. 2006, 20, 682–692. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Soltanian, S.; François, J.M.; Dhont, J.; Arnouts, S.; Sorgeloos, P.; Bossier, P. Enhanced disease resistance in Artemia by application of commercial β-glucans sources and chitin in a gnotobiotic Artemia challenge test. Fish Shellfish Immunol. 2007, 23, 1304–1314. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chang, J.; Zhang, W.; Mai, K.; Ma, H.; Liufu, Z.; Wang, X.; Ai, Q.; Xu, W. Effects of dietary β-glucan and glycyrrhizin on non-specific immunity and disease resistance of white shrimp, Litopenaeus vannamei (Boone) challenged with Vibrio alginolyticus. Aquac. Res. 2011, 42, 1101–1109. [Google Scholar] [CrossRef] [Scilit]
- Jueliang, P.; Chuchird, N.; Limsuwan, C. The Effects of Probiotics, β-1,3-glucan and organic Acid on Pacific White Shrimp Immune System and survival upon Challenge with Vibrio harveyi. Kasetsart Univ. Fish. Res. Bull. 2013, 37, 13. [Google Scholar]
- Misra, C.K.; Das, B.K.; Pradhan, J.; Pattnaik, P.; Sethi, S.; Mukherjee, S.C. Changes in lysosomal enzyme activity and protection against Vibrio infection in Macrobrachium rosenbergii (De Man) post larvae after bath immunostimulation with β-glucan. Fish Shellfish Immunol. 2004, 17, 389–395. [Google Scholar] [CrossRef] [Scilit]
- Meshram, S.J.; Murthy, H.S.; Ali, H.; Swain, H.S.; Ballyaya, A. Effect of dietary β-glucan on immune response and disease resistance against Aeromonas hydrophila in giant freshwater prawn, Macrobrachium rosenbergii (de Man. 1879). Aquac. Int. 2015, 23, 439–447. [Google Scholar] [CrossRef] [Scilit]
- Sahoo, P.K.; Das, A.; Mohanty, S.; Mohanty, B.R.; Pillai, B.R.; Mohanty, J. Dietary β-1,3-glucan improves the immunity and disease resistance of freshwater prawn Macrobrachium rosenbergii challenged with Aeromonas hydrophila. Aquac. Res. 2008, 39, 1574–1578. [Google Scholar] [CrossRef] [Scilit]
- Sung, H.H.; Kou, G.H.; Song, Y.L. Vibriosis Resistance Induced by Glucan Treatment in Tiger Shrimp (Penaeus monodon). Fish Pathol. 1994, 29, 11–17. [Google Scholar] [CrossRef] [Scilit]
- Han, B.; Baruah, K.; Nguyen, D.V.; Williams, D.L.; Devriendt, B.; Cox, E.; Bossier, P. Beta-glucan’s varying structure characteristics modulate survival and immune-related genes expression from Vibrio harveyi-infected Artemia franciscana in gnotobiotic conditions. Fish Shellfish Immunol. 2020, 102, 307–315. [Google Scholar] [CrossRef] [Scilit]
- Tian, J.; Yang, Y.; Xu, W.; Du, X.; Ye, Y.; Zhu, B.; Huang, Y.; Zhao, Y.; Li, Y. Effects of β-1,3-glucan on growth, immune responses, and intestinal microflora of the river prawn (Macrobrachium nipponense) and its resistance against Vibrio parahaemolyticus. Fish Shellfish Immunol. 2023, 142, 109142. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Loor, A.; Wang, D.; Bossier, P.; Nevejan, N. β-1,3-Glucan/chitin unmasking in the Saccharomyces cerevisiae mutant, Δmnn9, promotes immune response and resistance of the Pacific oyster (Crassostrea gigas) to Vibrio coralliilyticus infection. Fish Shellfish Immunol. 2022, 131, 470–479. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rojas-García, C.R.; Hasanuzzaman, A.F.M.; Sorgeloos, P.; Bossier, P. Cell wall deficient Saccharomyces cerevisiae strains as microbial diet for Artemia larvae: Protective effects against vibriosis and participation of phenoloxidase. J. Exp. Mar. Biol. Ecol. 2008, 360, 1–8. [Google Scholar] [CrossRef] [Scilit]
- Fehrenbach, G.W.; Tanoeiro, J.R.; Pogue, R.; Carter, F.; Lemos, M.F.L.; Murray, P.; Devine, D.; Rezoagli, E.; Major, I.; Murphy, E.J. Beta-glucan-enriched diets improve immune function, antioxidant activity, and survivability in challenged oysters. Food Hydrocoll. Health 2025, 8, 100227. [Google Scholar] [CrossRef] [Scilit]
- Wu, Y.S.; Tseng, T.Y.; Nan, F.H. Beta-1,3-1,6-glucan modulate the non-specific immune response to enhance the survival in the Vibrio alginolyticus infection of Taiwan abalone (Haliotis diversicolor supertexta). Fish Shellfish Immunol. 2016, 54, 556–563. [Google Scholar] [CrossRef] [Scilit]
- Valladares, A.; Domínguez-Borbor, C.; Echeverria, F.; Panchana, F.; Betancourt, I.; Sonnenholzner, S.; Bayot, B.; Rodríguez, J. The influence of temperature and β-1,3-glucans on the occurrence of white spot syndrome virus and white spot disease in post-larvae of Penaeus vannamei shrimp. Fish Shellfish Immunol. 2024, 154, 109938. [Google Scholar] [CrossRef] [Scilit]
- Licona-Jain, A.; Campa-Córdova, Á.; Luna-González, A.; Racotta, I.S.; Tello, M.; Angulo, C. Dietary supplementation of marine yeast Yarrowia lipolytica modulates immune response in Litopenaeus vannamei. Fish Shellfish Immunol. 2020, 105, 469–476. [Google Scholar] [CrossRef] [Scilit]
- Parmar, P.V.; Murthy, H.S.; Tejpal, C.S.; Naveen Kumar, B.T. Effect of brewer’s yeast on immune response of giant freshwater prawn, Macrobrachium rosenbergii, and its resistance to white muscle disease. Aquac. Int. 2012, 20, 951–964. [Google Scholar] [CrossRef] [Scilit]
- Jayaraj, S.S.; Thiagarajan, R.; Arumugam, M.; Mullainadhan, P. Isolation, purification and characterization of β-1,3-glucan binding protein from the plasma of marine mussel Perna viridis. Fish Shellfish Immunol. 2008, 24, 715–725. [Google Scholar] [CrossRef] [Scilit]
- Yao, C.L.; Wu, C.G.; Xiang, J.H.; Li, F.; Wang, Z.Y.; Han, X. The lysosome and lysozyme response in Chinese shrimp Fenneropenaeus chinensis to Vibrio anguillarum and laminarin stimulation. J. Exp. Mar. Biol. Ecol. 2008, 363, 124–129. [Google Scholar] [CrossRef] [Scilit]
- Ding, J.; Wang, R.; Yang, F.; Zhao, L.; Qin, Y.; Zhang, G.; Yan, X. Identification and characterization of a novel phage-type like lysozyme from Manila clam, ruditapes philippinarum. Dev. Comp. Immunol. 2014, 47, 81–89. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lin, T.; Xing, J.; Jiang, J.; Tang, X.; Zhan, W. β-glucan-stimulated activation of six enzymes in the haemocytes of the scallop Chlamys farreri at different water temperatures. Aquaculture 2011, 315, 213–221. [Google Scholar] [CrossRef] [Scilit]
- Itoh, N.; Kamitaka, R.; Takahashi, K.G.; Osada, M. Identification and characterization of multiple β-glucan binding proteins in the Pacific oyster, Crassostrea gigas. Dev. Comp. Immunol. 2010, 34, 445–454. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Loor, A.; Bossier, P.; Nevejan, N. Dietary substitution of microalgae with the Saccharomyces cerevisiae mutant, Δmnn9, for feeding Pacific oyster (Crassostrea gigas) juveniles. Aquaculture 2021, 534, 736253. [Google Scholar] [CrossRef] [Scilit]
- Prado-Alvarez, M.; Lynch, S.A.; Kane, A.; Darmody, G.; Pardo, B.G.; Martínez, P.; Cotterill, J.; Wontner-Smith, T.; Culloty, S.C. Oral immunostimulation of the oyster Ostrea edulis: Impacts on the parasite Bonamia ostreae. Fish Shellfish Immunol. 2015, 45, 43–51. [Google Scholar] [CrossRef] [Scilit]
- Jia, Z.; Liu, R.; Chang, Q.; Zhou, X.; De, X.; Yang, Z.; Li, Y.; Zhang, C.; Wang, F.; Ge, J. Proof of concept in utilizing the peptidoglycan skeleton of pathogenic bacteria as antigen delivery platform for enhanced immune response. Int. J. Biol. Macromol. 2024, 264, 130591. [Google Scholar] [CrossRef] [Scilit]
- Sugiyama, S.; Nakabayashi, K.; Baba, I.; Sasazuki, T.; Shirasawa, S. Role of epiregulin in peptidoglycan-induced proinflammatory cytokine production by antigen presenting cells. Biochem. Biophys. Res. Commun. 2005, 337, 271–274. [Google Scholar] [CrossRef] [Scilit]
- Wang, L.S.; Pan, L.J.; Shi, L.; Sun, Y.; Zhang, Y.L.; Zhou, D.Y. The apoptosis of experimental colorectal carcinoma cells induced by peptidoglycan of bifidobacterium and the expression of apoptotic regulating genes. Chin. J. Cancer Res. 1999, 11, 184–187. [Google Scholar] [CrossRef] [Scilit]
- Chu, X.H.; Yang, T.T.; Liu, Y.; Hong, L.; Jiao, T.; Meng, X.; Zhang, D.Z.; Wang, J.L.; Tang, B.P.; Zhou, C.L.; et al. Transcriptome analysis of differential expressed genes in hepatopancreas of Procambarus clarkii challenged with peptidoglycan. Fish Shellfish Immunol. 2019, 86, 311–318. [Google Scholar] [CrossRef] [Scilit]
- Fagutao, F.F.; Yasuike, M.; Caipang, C.M.; Kondo, H.; Hirono, I.; Takahashi, Y.; Aoki, T. Gene expression profile of hemocytes of kuruma shrimp, Marsupenaeus japonicus following peptidoglycan stimulation. Mar. Biotechnol. 2008, 10, 731–740. [Google Scholar] [CrossRef] [Scilit]
- Li, Y.T.; Tang, B.P.; Zhang, S.P.; Tang, Y.Y.; Wang, G.; Jiang, S.H.; Ge, B.M.; Zhang, D.Z.; Zhou, C.L.; Liu, Q.N.; et al. Transcriptome analysis of immune-related genes in Sesarmops sinensis hepatopancreas in reaction to peptidoglycan challenge. Genomics 2021, 113, 946–954. [Google Scholar] [CrossRef] [Scilit]
- Ni, D.; Song, L.; Wu, L.; Chang, Y.; Yu, Y.; Qiu, L.; Wang, L. Molecular cloning and mRNA expression of peptidoglycan recognition protein (PGRP) gene in bay scallop (Argopecten irradians, Lamarck 1819). Dev. Comp. Immunol. 2007, 31, 548–558. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yang, M.; Pan, T.; Duan, G.; Li, T.; Jiang, H.; Ling, J. Effect of peptidoglycan on hepatopancreas of female Chinese mitten crabs (Eriocheir sinensis). Aquac. Int. 2024, 32, 4901–4914. [Google Scholar] [CrossRef] [Scilit]
- Itami, T.; Asano, M.; Tokushige, K.; Kubono, K.; Nakagawa, A.; Takeno, N.; Nishimura, H.; Maeda, M.; Kondo, M.; Takahashi, Y. Enhancement of disease resistance of kuruma shrimp, Penaeus japonicus, after oral administration of peptidoglycan derived from Bifidobacterium thermophilum. Aquaculture 1998, 164, 277–288. [Google Scholar] [CrossRef] [Scilit]
- Hou, C.; Zhu, L.; Zheng, Y.; Shi, L.; Tan, B.; Zhang, S. Effects of dietary peptidoglycan on Litopenaeus vannamei: Growth performance, disease resistance, non-specific immunity and transcriptome analysis of immune response. Aquac. Rep. 2023, 31, 101676. [Google Scholar] [CrossRef] [Scilit]
- Apines-Amar, M.J.S.; Andrino, K.G.S.; Amar, E.C.; Cadiz, R.E.; Corre, V.L., Jr.; Jane, M.; Apines-Amar, S.; Grace, K.; Andrino, S.; Amar, E.C.; et al. Improved resistance against White Spot Virus (WSV) infection in tiger shrimp, Penaeus monodon by combined supplementation of peptidoglycan and mannan oligosaccharide (MOS). ELBA Bioflux 2014, 6, 1–9. Available online: http://www.elba.bioflux.com.ro (accessed on 30 December 2025).
- Boonyaratpalin, S.; Boonyaratpalin, M.; Supamattaya, K.; Toride, Y. Effects of peptidoglucan (PG) on growth, survival, immune responses, and tolerance to stress in black tiger shrimp, Penaeus monodon. Dis. Asian Aquac. 1995, 11, 469–477. [Google Scholar]
- Do Huu, H.; Jones, C.M. Effects of dietary mannan oligosaccharide supplementation on juvenile spiny lobster Panulirus homarus (Palinuridae). Aquaculture 2014, 432, 258–264. [Google Scholar] [CrossRef] [Scilit]
- Genc, M.A.; Aktas, M.; Genc, E.; Yilmaz, E. Effects of dietary mannan oligosaccharide on growth, body composition and hepatopancreas histology of Penaeus semisulcatus (de Haan 1844). Aquac. Nutr. 2007, 13, 156–161. [Google Scholar] [CrossRef] [Scilit]
- Lu, J.; Qi, C.; Limbu, S.M.; Han, F.; Yang, L.; Wang, X.; Qin, J.G.; Chen, L. Dietary mannan oligosaccharide (MOS) improves growth performance, antioxidant capacity, non-specific immunity and intestinal histology of juvenile Chinese mitten crabs (Eriocheir sinensis). Aquaculture 2019, 510, 337–346. [Google Scholar] [CrossRef] [Scilit]
- Mazlum, Y.; Yılmaz, E.; Genç, M.A.; Guner, O. A preliminary study on the use of mannan oligosaccharides (MOS) in freshwater crayfish, Astacus leptodactylus Eschscholtz, 1823 juvenile diets. Aquac. Int. 2011, 19, 111–119. [Google Scholar] [CrossRef] [Scilit]
- Pan, M.V.; Traifalgar, R.F.M.; Serrano, A.E.; Corre, V.L. Immunomodulatory and Growth Promoting Effects of Peptidoglycan Supplementation in Black Tiger Shrimp Penaeus monodon Fabricius 1798. Asian Fish. Sci. 2015, 28, 60–71. [Google Scholar] [CrossRef] [Scilit]
- Yang, J.; Wang, W.; Wei, X.; Qiu, L.; Wang, L.; Zhang, H.; Song, L. Peptidoglycan recognition protein of Chlamys farreri (CfPGRP-S1) mediates immune defenses against bacterial infection. Dev. Comp. Immunol. 2010, 34, 1300–1307. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kong, X.; Liu, H.; Li, Y.; Zhang, H. Two novel short Peptidoglycan Recognition Proteins (PGRPs) from the deep sea vesicomyidae clam archivesica packardana: Identification, recombinant expression and bioactivity. Front. Physiol. 2018, 9, 1476. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kong, X.; Wang, W.; Xia, S.; Zhi, Y.; Cai, Y.; Zhang, H.; Shen, X. Molecular and functional characterization of short peptidoglycan recognition proteins in Vesicomyidae clam. Dev. Comp. Immunol. 2025, 162, 105284. [Google Scholar] [CrossRef] [Scilit]
- Meng, Y.; Dai, W.; Lin, Z.; Zhang, W.; Dong, Y. Expression and functional characterization of peptidoglycan recognition protein-S6 involved in antibacterial responses in the razor clam Sinonovacula constricta. Dev. Comp. Immunol. 2022, 129, 104331. [Google Scholar] [CrossRef] [Scilit]
- Wei, X.; Yang, J.; Yang, D.; Xu, J.; Liu, X.; Yang, J.; Fang, J.; Qiao, H. Molecular cloning and mRNA expression of two peptidoglycan recognition protein (PGRP) genes from mollusk Solen grandis. Fish Shellfish Immunol. 2012, 32, 178–185. [Google Scholar] [CrossRef] [Scilit]
- Yang, D.; Han, Y.; Liu, Y.; Cao, R.; Wang, Q.; Dong, Z.; Liu, H.; Zhang, X.; Zhang, Q.; Zhao, J. A peptidoglycan recognition protein involved in immune recognition and immune defenses in Ruditapes philippinarum. Fish Shellfish Immunol. 2019, 88, 441–448. [Google Scholar] [CrossRef] [Scilit]
- Huang, Y.; Pan, J.; Li, X.; Ren, Q.; Zhao, Z. Molecular cloning and functional characterization of a short peptidoglycan recognition protein from triangle-shell pearl mussel (Hyriopsis cumingii). Fish Shellfish Immunol. 2019, 86, 571–580. [Google Scholar] [CrossRef] [Scilit]
- Liao, Z.; Yang, Z.; Wang, Y.; He, J.; He, Z.; Zhang, X.; Buttino, I.; Qi, P.; Fan, M.; Guo, B.; et al. Molecular characterization of peptidoglycan recognition proteins from Mytilus coruscus. Fish Shellfish Immunol. 2022, 131, 612–623. [Google Scholar] [CrossRef] [Scilit]
- Gorbushin, A.M. Identification of peptidoglycan recognition proteins in hemocytes and kidney of common periwinkle Littorina littorea. Fish Shellfish Immunol. 2022, 120, 11–14. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Premachandra, H.K.A.; Elvitigala, D.A.S.; Whang, I.; Lee, J. Identification of a novel molluscan short-type peptidoglycan recognition protein in disk abalone (Haliotis discus discus) involved in host antibacterial defense. Fish Shellfish Immunol. 2014, 39, 99–107. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Itoh, N.; Takahashi, K.G. Distribution of multiple peptidoglycan recognition proteins in the tissues of Pacific oyster, Crassostrea gigas. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 2008, 150, 409–417. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Itoh, N.; Takahashi, K.G. A novel peptidoglycan recognition protein containing a goose-type lysozyme domain from the Pacific oyster, Crassostrea gigas. Mol. Immunol. 2009, 46, 1768–1774. [Google Scholar] [CrossRef] [Scilit]
- Yang, C.; Wang, L.; Jia, Z.; Yi, Q.; Xu, Q.; Wang, W.; Gong, C.; Liu, C.; Song, L. Two short peptidoglycan recognition proteins from Crassostrea gigas with similar structure exhibited different PAMP binding activity. Dev. Comp. Immunol. 2017, 70, 9–18. [Google Scholar] [CrossRef] [Scilit]
- Zhang, Y.; Yu, Z. The first evidence of positive selection in peptidoglycan recognition protein (PGRP) genes of Crassostrea gigas. Fish Shellfish Immunol. 2013, 34, 1352–1355. [Google Scholar] [CrossRef] [Scilit]
- Imler, J.L.; Hoffmann, J.A. Toll receptors in innate immunity. Trends Cell Biol. 2001, 11, 304–311. [Google Scholar] [CrossRef] [Scilit]
- De Zoysa, M.; Nikapitiya, C.; Oh, C.; Whang, I.; Lee, J.S.; Jung, S.J.; Choi, C.Y.; Lee, J. Molecular evidence for the existence of lipopolysaccharide-induced TNF-α factor (LITAF) and Rel/NF-kB pathways in disk abalone (Haliotis discus). Fish Shellfish Immunol. 2010, 28, 754–763. [Google Scholar] [CrossRef] [Scilit]
- Alexander, C.; Rietschel, E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7, 167–202. [Google Scholar] [CrossRef] [Scilit]
- Iwanaga, S.; Kawabata, S.I.; Muta, T. New types of clotting factors and defense molecules found in horseshoe crab hemolymph: Their structures and functions. J. Biochem. 1998, 123, 1–15. [Google Scholar] [CrossRef] [Scilit]
- Saito, T.; Hatada, M.; Iwanaga, S.; Kawabata, S.I. A newly identified horseshoe crab lectin with binding specificity to O-antigen of bacterial lipopolysaccharides. J. Biol. Chem. 1997, 272, 30703–30708. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Elvitigala, D.A.S.; Premachandra, H.K.A.; Whang, I.; Nam, B.H.; Lee, J. Molecular insights of the first gastropod TLR counterpart from disk abalone (Haliotis discus discus), revealing its transcriptional modulation under pathogenicstress. Fish Shellfish Immunol. 2013, 35, 334–342. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zoysa, M.; De Nikapitiya, C.; Moon, D.; Whang, I.; Kim, G.; Lee, J. Fish & Shellfish Immunology A novel Fas ligand in mollusk abalone: Molecular characterization, immune responses and biological activity of the recombinant protein. Fish Shellfish Immunol. 2009, 27, 423–432. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jia, Z.; Zhang, T.; Jiang, S.; Wang, M.; Cheng, Q.; Sun, M.; Wang, L.; Song, L. An integrin from oyster Crassostrea gigas mediates the phagocytosis toward Vibrio splendidus through LPS binding activity. Dev. Comp. Immunol. 2015, 53, 253–264. [Google Scholar] [CrossRef] [Scilit]
- Meng, J.; Zhang, L.; Huang, B.; Li, L.; Zhang, G. Comparative analysis of oyster (Crassostrea gigas) immune responses under challenge by different Vibrio strains and conditions. Molluscan Res. 2015, 35, 1–11. [Google Scholar] [CrossRef] [Scilit]
- Tang, C.; Qiao, X.; Jin, Y.; Yang, W.; Yu, Z.; Wang, L.; Song, L. An LPS-induced TNF-α factor involved in immune response of oyster Crassostrea gigas by regulating haemocytes apoptosis. Fish Shellfish Immunol. 2024, 148, 109513. [Google Scholar] [CrossRef] [Scilit]
- Xian, J.A.; Zhang, X.X.; Guo, H.; Wang, D.M.; Wang, A.L. Cellular responses of the tiger shrimp Penaeus monodon haemocytes after lipopolysaccharide injection. Fish Shellfish Immunol. 2016, 54, 385–390. [Google Scholar] [CrossRef] [Scilit]
- Xian, J.A.; Zhang, X.X.; Wang, D.M.; Li, J.T.; Zheng, P.H.; Lu, Y.P. Various cellular responses of different shrimp haemocyte subpopulations to lipopolysaccharide stimulation. Fish Shellfish Immunol. 2017, 69, 195–199. [Google Scholar] [CrossRef] [Scilit]
- Okumura, T. Effects of lipopolysaccharide on gene expression of antimicrobial peptides (penaeidins and crustin), serine proteinase and prophenoloxidase in haemocytes of the Pacific white shrimp, Litopenaeus vannamei. Fish Shellfish Immunol. 2007, 22, 68–76. [Google Scholar] [CrossRef] [Scilit]
- Genio, J.E.J.; Traifalgar, R.F.M.; Corre, V.L. Dietary administration of crude lipopolysaccharide from Vibrio harveyi enhanced resistance of tiger shrimp, Penaeus monodon post larvae against white spot syndrome virus infection. AACL Bioflux 2014, 7, 342–350. [Google Scholar]
- Genio, J.E.; Traifalgar, R.F.; Corre, V. Application Frequency of Dietary Vibrio harveyi Lipopolysaccharide (LPS) on Growth and White Spot Syndrome Virus Resistance of Post Larvae Penaeus monodon. Isr. J. Aquac.-Bamidgeh 2015, 67, 20717. [Google Scholar]
- Arayamethakorn, S.; Uengwetwanit, T.; Karoonuthaisiri, N.; Methacanon, P.; Rungrassamee, W. Comparative effects of different bacterial lipopolysaccharides on modulation of immune levels to improve survival of the black tiger shrimp. J. Invertebr. Pathol. 2023, 197, 107872. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Traifalgar, R.F.M.; Corre, V.L.; Serrano, A.E. Efficacy of dietary immunostimulants to enhance the immunological responses and vibriosis resistance of juvenile Penaeus monodon. J. Fish. Aquat. Sci. 2013, 8, 340–354. [Google Scholar] [CrossRef] [Scilit]
- Takahashi, Y.; Kondo, M.; Itami, T.; Honda, T.; Inagawa, H.; Nishizawa, T.; Soma, G.I.; Yokomizo, Y. Enhancement of disease resistance against penaeid acute viraemia and induction of virus-inactivating activity in haemolymph of kuruma shrimp, Penaeus japonicus, by oral administration of Pantoea agglomerans lipopolysaccharide (LPS). Fish Shellfish Immunol. 2000, 10, 555–558. [Google Scholar] [CrossRef] [Scilit]
- Felix, S. Pro-PO Based Immunomodulatory Effect of Glucan and LPS on Tiger Shrimp, Penaeus monodon (Fabricius). Dis. Asian Aquac. V 2005, 1998, 477–482. [Google Scholar]
- Yan, Z.; Zhu, L.; Hou, C.; Zheng, Y.; Guo, H.; Shi, L.; Tan, B.; Zhang, S. The enhancement effect of low-dose dietary lipopolysaccharide on the growth and immunity of Litopenaeus vannamei, and transcriptome analysis. Fish Shellfish Immunol. 2023, 133, 108517. [Google Scholar] [CrossRef] [Scilit]
- Sequeira, T.; Tavares, D.; Arala-Chaves, M. Evidence for circulating hemocyte proliferation in the shrimp Penaeus japonicus. Dev. Comp. Immunol. 1996, 20, 97–104. [Google Scholar] [CrossRef] [Scilit]
- Van De Braak, C.B.T.; Botterblom, M.H.A.; Liu, W.; Taverne, N.; Van Der Knaap, W.P.W.; Rombout, J.H.W.M. The role of the haematopoietic tissue in haemocyte production and maturation in the black tiger shrimp (Penaeus monodon). Fish Shellfish Immunol. 2002, 12, 253–272. [Google Scholar] [CrossRef] [Scilit]
- Rungrassamee, W.; Maibunkaew, S.; Karoonuthaisiri, N.; Jiravanichpaisal, P. Application of bacterial lipopolysaccharide to improve survival of the black tiger shrimp after Vibrio harveyi exposure. Dev. Comp. Immunol. 2013, 41, 257–262. [Google Scholar] [CrossRef] [Scilit]
- Costa, M.M.; Prado-Alvarez, M.; Gestal, C.; Li, H.; Roch, P.; Novoa, B.; Figueras, A. Functional and molecular immune response of Mediterranean mussel (Mytilus galloprovincialis) haemocytes against pathogen-associated molecular patterns and bacteria. Fish Shellfish Immunol. 2009, 26, 515–523. [Google Scholar] [CrossRef] [Scilit]
- Xiao, W.; Song, F.; Yang, Z.; Wu, X.; Zhang, X.; He, J.; Wang, Y.; Buttino, I.; Yan, X.; Liao, Z. Molecular responses of Mytilus coruscus hemocytes to lipopolysaccharide and peptidoglycan as revealed by 4D-DIA based quantitative proteomics analysis. Fish Shellfish Immunol. 2025, 158, 110143. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sung, H.H.; Yang, Y.L.; Song, Y.L. Enhancement of Microbicidal Activity in the Tiger Shrimp Penaeus monodon via immunostimulation. J. Crustac. Biol. 1996, 16, 278–284. [Google Scholar] [CrossRef] [Scilit]
- Alabi, A.O.; Jones, D.A.; Latchford, J.W. The efficacy of immersion as opposed to oral vaccination of Penaeus indicus larvae against Vibrio harveyi. Aquaculture 1999, 178, 1–11. [Google Scholar] [CrossRef] [Scilit]
- Itami, T.; Takahashi, Y.; Nakamura, Y. Efficacy of vaccination against vibriosis in cultured kuruma prawns Penaeus japonicus. J. Aquat. Anim. Health 1989, 1, 238–242. [Google Scholar] [CrossRef] [Scilit]
- Teunissen, O.S.P.; Faber, R.; Booms, G.H.R.; Latscha, T.; Boon, J.H. Influence of vaccination on vibriosis resistance of the giant black tiger shrimp Penaeus monadon (Fabricius). Aquaculture 1998, 164, 359–366. [Google Scholar] [CrossRef] [Scilit]
- Wongtavatchai, J.; López-Dóriga, M.V.; Francis, M.J. Effect of AquaVacTM VibromaxTM on size and health of post larva stage of Pacific White shrimp Litopenaeus vannamei and Black Tiger shrimp Penaeus monodon. Aquaculture 2010, 308, 75–81. [Google Scholar] [CrossRef] [Scilit]
- Powell, A.; Pope, E.C.; Eddy, F.E.; Roberts, E.C.; Shields, R.J.; Francis, M.J.; Smith, P.; Topps, S.; Reid, J.; Rowley, A.F. Enhanced immune defences in Pacific white shrimp (Litopenaeus vannamei) post-exposure to a vibrio vaccine. J. Invertebr. Pathol. 2011, 107, 95–99. [Google Scholar] [CrossRef] [Scilit]
- Venegas, C.A.; Nonaka, L.; Mushiake, K.; Nishizawa, T.; Muroga, K. Quasi-immune response of Penaeus japonicus to penaeid rod-shaped DNA virus (PRDV). Dis. Aquat. Org. 2000, 42, 83–89. [Google Scholar] [CrossRef] [Scilit]
- Wu, J.L.; Nishioka, T.; Mori, K.; Nishizawa, T.; Muroga, K. A time-course study on the resistance of Penaeus japonicus induced by artificial infection with white spot syndrome virus. Fish Shellfish Immunol. 2002, 13, 391–403. [Google Scholar] [CrossRef] [Scilit]
- Singh, I.S.B.; Manjusha, M.; Pai, S.S.; Philip, R. Fenneropenaeus indicus is protected from white spot disease by oral administration of inactivated white spot syndrome virus. Dis. Aquat. Org. 2005, 66, 265–270. [Google Scholar] [CrossRef] [Scilit]
- Zhu, F.; Du, H.; Miao, Z.G.; Quan, H.Z.; Xu, Z.R. Protection of Procambarus clarkii against white spot syndrome virus using inactivated WSSV. Fish Shellfish Immunol. 2009, 26, 685–690. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhu, F.; Miao, Z.G.; Li, Y.H.; Du, H.H.; Xu, Z.R. Oral vaccination trials with crayfish, Procambarus clarkii, to induce resistance to the white spot syndrome virus. Aquac. Res. 2009, 40, 1793–1798. [Google Scholar] [CrossRef] [Scilit]
- Sudheer, N.S.; Poulose, G.; Thomas, A.; Viswanath, K.; Kulkarni, A.; Narayanan, R.B.; Philip, R.; Singh, I.S.B. Expression profile of bio-defense genes in Penaeus monodon gills in response to formalin inactivated white spot syndrome virus vaccine. Antivir. Res. 2015, 117, 60–68. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lin, Y.C.; Chen, J.C.; Morni, W.Z.W.; Putra, D.F.; Huang, C.L.; Li, C.C.; Hsieh, J.F. Vaccination Enhances Early Immune Responses in White Shrimp Litopenaeus vannamei after Secondary Exposure to Vibrio alginolyticus. PLoS ONE 2013, 8, e69722. [Google Scholar] [CrossRef] [Scilit]
- Abdulrazzak, L.; Hisham, N.A.; Abudarwish, M.M.; Sheikh, H.I. Efficacy of vaccine from whole killed Vibrio alginolyticus cells on the immune response of white shrimp (Litopenaeus vannamei). Iraqi J. Vet. Sci. 2024, 38, 37–44. [Google Scholar] [CrossRef] [Scilit]
- Wang, J.; Yang, B.; Wang, W.; Song, X.; Jiang, Q.; Qiu, L.; Wang, L.; Song, L. The enhanced immune protection in Chinese mitten crab Eriocheir sinensis against the second exposure to bacteria Aeromonas hydrophila. Front. Immunol. 2019, 10, 2041. [Google Scholar] [CrossRef] [Scilit]
- Zhang, X.; Zeng, X.; Sun, Y.; Wang, Y.; Zhang, Z. Enhanced Immune Protection of Mud Crab Scylla paramamosain in Response to the Secondary Challenge by Vibrio parahaemolyticus. Front. Immunol. 2020, 11, 565958. [Google Scholar] [CrossRef] [Scilit]
- Yang, W.; Tran, N.T.; Zhu, C.; Zhang, M.; Yao, D.; Aweya, J.J.; Gong, Y.; Ma, H.; Zhang, Y.; Li, G.; et al. Enhanced immune responses and protection against the secondary infection in mud crab (Scylla paramamosain) primed with formalin-killed Vibrio parahemolyticus. Aquaculture 2020, 529, 735671. [Google Scholar] [CrossRef] [Scilit]
- Patil, P.K.; Gopal, C.; Panigrahi, A.; Rajababu, D.; Pillai, S.M. Oral administration of formalin killed Vibrio anguillarum cells improves growth and protection against challenge with Vibrio harveyi in banana shrimp. Lett. Appl. Microbiol. 2014, 58, 213–218. [Google Scholar] [CrossRef] [Scilit]
- Hsu, C.H.; Chen, J.C.; Lin, Y.C.; Chen, Y.Y.; Liu, P.C.; Lin, B.W.; Hsieh, J.F. White shrimp Litopenaeus vannamei that have received mixtures of heat-killed and formalin-inactivated Vibrio alginolyticus and V. harveyi exhibit recall memory and show increased phagocytosis and resistance to Vibrio infection. Fish Shellfish Immunol. 2021, 112, 151–158. [Google Scholar] [CrossRef] [Scilit]
- Zhang, T.; Qiu, L.; Sun, Z.; Wang, L.; Zhou, Z.; Liu, R.; Yue, F.; Sun, R.; Song, L. The specifically enhanced cellular immune responses in Pacific oyster (Crassostrea gigas) against secondary challenge with Vibrio splendidus. Dev. Comp. Immunol. 2014, 45, 141–150. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nathan, C.; Cunningham-Bussel, A. Beyond oxidative stress: An immunologist’s guide to reactive oxygen species. Nat. Rev. Immunol. 2013, 13, 349–361. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yang, S.; Lian, G. ROS and diseases: Role in metabolism and energy supply. Mol. Cell. Biochem. 2020, 467, 1–12. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cong, M.; Song, L.; Wang, L.; Zhao, J.; Qiu, L.; Li, L.; Zhang, H. The enhanced immune protection of Zhikong scallop Chlamys farreri on the secondary encounter with Listonella anguillarum. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 2008, 151, 191–196. [Google Scholar] [CrossRef] [Scilit]
- Wang, J.; Wang, L.; Yang, C.; Jiang, Q.; Zhang, H.; Yue, F.; Huang, M.; Sun, Z.; Song, L. The response of mRNA expression upon secondary challenge with Vibrio anguillarum suggests the involvement of C-lectins in the immune priming of scallop Chlamys farreri. Dev. Comp. Immunol. 2013, 40, 142–147. [Google Scholar] [CrossRef] [Scilit]
- Li, S.; Nie, H.; Huo, Z.; Yan, X. Transcriptomic signatures related to the immune priming of Ruditapes philippinarum in response to the re-infection of Vibrio anguillarum. Fish Shellfish Immunol. 2025, 161, 110263. [Google Scholar] [CrossRef] [Scilit]
- Travers, M.; Meistertzheim, A.; Cardinaud, M.; Friedman, C.S.; Huchette, S.; Moraga, D.; Paillard, C. Gene expression patterns of abalone, Haliotis tuberculata, during successive infections by the pathogen Vibrio harveyi. J. Invertebr. Pathol. 2011, 105, 289–297. [Google Scholar] [CrossRef] [Scilit]
- Dubief, B.; Nunes, F.L.D.; Basuyaux, O.; Paillard, C. Immune priming and portal of entry effectors improve response to vibrio infection in a resistant population of the European abalone. Fish Shellfish Immunol. 2017, 60, 255–264. [Google Scholar] [CrossRef] [Scilit]
- Macey, B.M.; Coyne, V.E. Improved growth rate and disease resistance in farmed Haliotis midae through probiotic treatment. Aquaculture 2005, 245, 249–261. [Google Scholar] [CrossRef] [Scilit]
- Jiang, H.F.; Liu, X.L.; Chang, Y.Q.; Liu, M.T.; Wang, G.X. Effects of dietary supplementation of probiotic Shewanella colwelliana WA64, Shewanella olleyana WA65 on the innate immunity and disease resistance of abalone, Haliotis Discus Hannai Ino. Fish Shellfish Immunol. 2013, 35, 86–91. [Google Scholar] [CrossRef] [Scilit]
- Silva-Aciares, F.; Moraga, D.; Auffret, M.; Tanguy, A.; Riquelme, C. Transcriptomic and cellular response to bacterial challenge (pathogenic Vibrio parahaemolyticus) in farmed juvenile Haliotis rufescens fed with or without probiotic diet. J. Invertebr. Pathol. 2013, 113, 163–176. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Grandiosa, R.; Young, T.; Van Nguyen, T.; Mérien, F.; Alfaro, A.C. Immune response in probiotic-fed New Zealand black-footed abalone (Haliotis iris) under Vibrio splendidus challenge. Fish Shellfish Immunol. 2020, 104, 633–639. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yao, T.; Lu, J.; Bai, C.; Xie, Z.; Ye, L. The Enhanced Immune Protection in Small Abalone Haliotis diversicolor Against a Secondary Infection With Vibrio harveyi. Front. Immunol. 2021, 12, 1–13. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, X.; Guo, M.; Sun, Y.; Wang, Y.; Zhang, Z. Transcriptomic analysis and discovery of genes involving in enhanced immune protection of Pacific abalone (Haliotis discus hannai) in response to the re-infection of Vibrio parahaemolyticus. Fish Shellfish Immunol. 2022, 125, 128–140. [Google Scholar] [CrossRef] [Scilit]
- de Kantzow, M.C.; Whittington, R.J.; Hick, P. Prior exposure to Ostreid herpesvirus 1 (OsHV-1) at 18 °C is associated with improved survival of juvenile Pacific oysters (Crassostrea gigas) following challenge at 22 °C. Aquaculture 2019, 507, 443–450. [Google Scholar] [CrossRef] [Scilit]
- Liu, O.M.; Hick, P.M.; Whittington, R.J. The Resistance to Lethal Challenge with Ostreid herpesvirus-1 of Pacific Oysters (Crassostrea gigas) Previously Exposed to This Virus. Viruses 2023, 15, 1706. [Google Scholar] [CrossRef] [Scilit]
- Morga, B.; Mège, M.; Faury, N.; Dégremont, L.; Petton, B.; Pépin, J.F.; Renault, T.; Montagnani, C. Antiviral protection in the Pacific oyster Crassostrea (Magallana) gigas against OsHV-1 infection using UV-inactivated virus. Front. Mar. Sci. 2024, 11, 1378511. [Google Scholar] [CrossRef] [Scilit]
- Dolashka, P.; Dolashki, A.; Van Beeumen, J.; Floetenmeyer, M.; Velkova, L.; Stevanovic, S.; Voelter, W. Antimicrobial Activity of Molluscan Hemocyanins from Helix and Rapana Snails. Curr. Pharm. Biotechnol. 2016, 17, 263–270. [Google Scholar] [CrossRef] [Scilit]
- Tincu, J.A.; Taylor, S.W. Antimicrobial peptides from marine invertebrates. Antimicrob. Agents Chemother. 2004, 48, 3645–3654. [Google Scholar] [CrossRef] [Scilit]
- Kaizu, A.; Fagutao, F.F.; Kondo, H.; Aoki, T.; Hirono, I. Functional analysis of C-type lysozyme in penaeid shrimp. J. Biol. Chem. 2011, 286, 44344–44349. [Google Scholar] [CrossRef] [Scilit]
- Seo, J.K.; Go, H.J.; Kim, C.H.; Nam, B.H.; Park, N.G. Antimicrobial peptide, hdMolluscidin, purified from the gill of the abalone, Haliotis discus. Fish Shellfish Immunol. 2016, 52, 289–297. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Morohoshi, T.; Ebata, A.; Nakazawa, S.; Kato, N.; Ikeda, T. N-acyl Homoserine Lactone-Producing or -Degrading Bacteria Isolated from the Intestinal Microbial Flora of Ayu Fish (Plecoglossus altivelis). Microbes Environ. 2005, 20, 264–268. [Google Scholar] [CrossRef] [Scilit]
- Turick, C.E.; Tisa, L.S.; Caccavo, F. Melanin production and use as a soluble electron shuttle for Fe(III) oxide reduction and as a terminal electron acceptor by Shewanella algae BrY. Appl. Environ. Microbiol. 2002, 68, 2436–2444. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zadeh, S.S.; Saad, C.R.; Christianus, A.; Kamarudin, M.S.; Sijam, K.; Shamsudin, M.N.; Neela, V.K. Assessment of growth condition for a candidate probiotic, Shewanella algae, isolated from digestive system of a healthy juvenile Penaeus monodon. Aquac. Int. 2010, 18, 1017–1026. [Google Scholar] [CrossRef] [Scilit]
- Silva-Aciares, F.R.; Carvajal, P.O.; Mejías, C.A.; Riquelme, C.E. Use of macroalgae supplemented with probiotics in the Haliotis rufescens (Swainson, 1822) culture in Northern Chile. Aquac. Res. 2011, 42, 953–961. [Google Scholar] [CrossRef] [Scilit]
- Norouzitallab, P.; Biswas, P.; Baruah, K.; Bossier, P. Multigenerational immune priming in an invertebrate parthenogenetic artemia to a pathogenic Vibrio campbellii. Fish Shellfish Immunol. 2015, 42, 426–429. [Google Scholar] [CrossRef] [Scilit]
- Norouzitallab, P.; Baruah, K.; Biswas, P.; Vanrompay, D.; Bossier, P. Probing the phenomenon of trained immunity in invertebrates during a transgenerational study, using brine shrimp Artemia as a model system. Sci. Rep. 2016, 6, 21166. [Google Scholar] [CrossRef] [Scilit]
- Norouzitallab, P.; Baruah, K.; Muthappa, D.M.; Bossier, P. Non-lethal heat shock induces HSP70 and HMGB1 protein production sequentially to protect Artemia franciscana against Vibrio campbellii. Fish Shellfish Immunol. 2015, 42, 395–399. [Google Scholar] [CrossRef] [Scilit]
- Roy, S.; Baruah, K.; Bossier, P.; Vanrompay, D.; Norouzitallab, P. Induction of transgenerational innate immune memory against Vibrio infections in a brine shrimp (Artemia franciscana) model. Aquaculture 2022, 557, 738309. [Google Scholar] [CrossRef] [Scilit]
- Yuan, H.; Lan, P.; He, Y.; Li, C.; Ma, X. Effect of the Modifications on the Physicochemical and Biological Properties of β-glucan—A critical Review. Molecules 2020, 25, 57. [Google Scholar] [CrossRef] [Scilit]
- Han, B.; Baruah, K.; Cox, E.; Vanrompay, D.; Bossier, P. Structure-Functional Activity Relationship of β-Glucans from the Perspective of Immunomodulation: A Mini-Review. Front. Immunol. 2020, 11, 658. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ma, J.; Bruce, T.J.; Jones, E.M.; Cain, K.D. A review of fish vaccine development strategies: Conventional methods and modern biotechnological approaches. Microorganisms 2019, 7, 569. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jonjaroen, V.; Charoonnart, P.; Jitrakorn, S.; Payongsri, P.; Surarit, R.; Saksmerprome, V.; Niamsiri, N. Nanoparticles-based double-stranded RNA delivery as an antiviral agent in shrimp aquaculture. Rev. Aquac. 2024, 16, 1647–1673. [Google Scholar] [CrossRef] [Scilit]
- Mondal, H.; Thomas, J. A review on the recent advances and application of vaccines against fish pathogens in aquaculture. Aquac. Int. 2022, 30, 1971–2000. [Google Scholar] [CrossRef] [Scilit]
- Martins, N.E.; Faria, V.G.; Teixeira, L.; Magalhães, S.; Sucena, É. Host Adaptation Is Contingent upon the Infection Route Taken by Pathogens. PLoS Pathog. 2013, 9, e1003601. [Google Scholar] [CrossRef] [Scilit]
- Ashe, A.; Sarkies, P.; Le Pen, J.; Tanguy, M.; Miska, E.A. Antiviral RNA Interference against Orsay Virus Is neither Systemic nor Transgenerational in Caenorhabditis elegans. J. Virol. 2015, 89, 12035–12046. [Google Scholar] [CrossRef] [Scilit]
- Sterken, M.G.; Snoek, L.B.; Bosman, K.J.; Daamen, J.; Riksen, J.A.G.; Bakker, J.; Pijlman, G.P.; Kammenga, J.E. A heritable antiviral RNAi response limits orsay virus infection in Caenorhabditis elegans N2. PLoS ONE 2014, 9, e89760. [Google Scholar] [CrossRef] [Scilit]
- Kim, M.J.; Shin, D.J.; Kim, K.I. Relative risk assessment: Influence of cannibalism on white spot syndrome virus transmission in whiteleg shrimp (Penaeus vannamei) under different conditions. Aquac. Int. 2023, 33, 3. [Google Scholar] [CrossRef] [Scilit]
- Brokordt, K.; Defranchi, Y.; Espósito, I.; Cárcamo, C.; Schmitt, P.; Mercado, L.; De la Fuente-Ortega, E.; Rivera-Ingraham, G.A. Reproduction immunity trade-off in a mollusk: Hemocyte energy metabolism underlies cellular and molecular immune responses. Front. Physiol. 2019, 10, 77. [Google Scholar] [CrossRef] [Scilit]
- Hartmann, D.; Adams, J.S.; Meeker, A.K.; Schneider, M.A.; Lenz, B.F.; Talmadge, J.E. Dissociation of Therapeutic and Toxic Effects of Polyinosinic-Polycytidylic Acid Admixed with Poly-L-lysine and Solubilized with Carboxymethyl Cellulose in Tumor-bearing Mice. Cancer Res. 1986, 46, 1331–1338. [Google Scholar]
- Hartmann, D.; Schneider Mark, A.; Lenz Barbara, F.; Talmadge James, E. Toxicity of Polyinosinic-Polycytidylic Acid Admixed with Poly-L-Lysine and Solubilized with Carboxymethylcellulose in Mice. Pathol. Immunopathol. Res. 1987, 6, 37–50. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Homan, E.R.; Zendzian, R.P.; Schott, L.D.; Levy, H.B.; Adamson, R.H. Studies on Poly I:C toxicity in experimental animals. Toxicol. Appl. Pharmacol. 1972, 23, 579–588. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Prigot-Maurice, C.; Depeux, C.; Paulhac, H.; Braquart-Varnier, C.; Beltran-Bech, S. Immune priming in Armadillidium vulgare against Salmonella enterica: Direct or indirect costs on life history traits? ZooKeys 2022, 1101, 131–158. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lanz-Mendoza, H.; Contreras-Garduño, J. Innate immune memory in invertebrates: Concept and potential mechanisms. Dev. Comp. Immunol. 2022, 127, 104285. [Google Scholar] [CrossRef] [Scilit]
- Dhinaut, J.; Chogne, M.; Moret, Y. Immune priming specificity within and across generations reveals the range of pathogens affecting evolution of immunity in an insect. J. Anim. Ecol. 2018, 87, 448–463. [Google Scholar] [CrossRef] [Scilit]
- Dubuffet, A.; Zanchi, C.; Boutet, G.; Moreau, J.; Teixeira, M.; Moret, Y. Trans-generational Immune Priming Protects the Eggs Only against Gram-Positive Bacteria in the Mealworm Beetle. PLoS Pathog. 2015, 11, e1005178. [Google Scholar] [CrossRef] [Scilit]
- Linder, J.E.; Promislow, D.E.L. Cross-generational fitness effects of infection in Drosophila melanogaster. Fly 2009, 3, 143–150. [Google Scholar] [CrossRef] [Scilit]
- Pigeault, R.; Vézilier, J.; Nicot, A.; Gandon, S.; Rivero, A. Transgenerational effect of infection in Plasmodium-infected mosquitoes. Biol. Lett. 2015, 11, 20141025. [Google Scholar] [CrossRef] [Scilit]
- Sadd, B.M.; Schmid-Hempel, P. A distinct infection cost associated with trans-generational priming of antibacterial immunity in bumble-bees. Biol. Lett. 2009, 5, 798–801. [Google Scholar] [CrossRef] [Scilit]
- Trauer, U.; Hilker, M. Parental Legacy in Insects: Variation of Transgenerational Immune Priming during Offspring Development. PLoS ONE 2013, 8, e63392. [Google Scholar] [CrossRef] [Scilit]
- Zanchi, C.; Troussard, J.P.; Moreau, J.; Moret, Y. Relationship between maternal transfer of immunity and mother fecundity in an insect. Proc. R. Soc. B Biol. Sci. 2012, 279, 3223–3230. [Google Scholar] [CrossRef] [Scilit]
- Torgerson, C.J. Publication bias: The achilles’ heel of systematic reviews? Br. J. Educ. Stud. 2006, 54, 89–102. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

